<SEC-DOCUMENT>0000950103-25-012738.txt : 20251002
<SEC-HEADER>0000950103-25-012738.hdr.sgml : 20251002
<ACCEPTANCE-DATETIME>20251002134722
ACCESSION NUMBER:		0000950103-25-012738
CONFORMED SUBMISSION TYPE:	424B2
PUBLIC DOCUMENT COUNT:		14
FILED AS OF DATE:		20251002
DATE AS OF CHANGE:		20251002

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CITIGROUP INC
		CENTRAL INDEX KEY:			0000831001
		STANDARD INDUSTRIAL CLASSIFICATION:	NATIONAL COMMERCIAL BANKS [6021]
		ORGANIZATION NAME:           	02 Finance
		EIN:				521568099
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B2
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-270327
		FILM NUMBER:		251368014

	BUSINESS ADDRESS:	
		STREET 1:		388 GREENWICH STREET
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10013
		BUSINESS PHONE:		2125591000

	MAIL ADDRESS:	
		STREET 1:		388 GREENWICH STREET
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10013

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TRAVELERS GROUP INC
		DATE OF NAME CHANGE:	19950519

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TRAVELERS INC
		DATE OF NAME CHANGE:	19940103

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PRIMERICA CORP /NEW/
		DATE OF NAME CHANGE:	19920703

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Citigroup Global Markets Holdings Inc.
		CENTRAL INDEX KEY:			0000200245
		STANDARD INDUSTRIAL CLASSIFICATION:	SECURITY BROKERS, DEALERS & FLOTATION COMPANIES [6211]
		ORGANIZATION NAME:           	02 Finance
		EIN:				112418067
		STATE OF INCORPORATION:			NY
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B2
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-270327-01
		FILM NUMBER:		251368015

	BUSINESS ADDRESS:	
		STREET 1:		388 GREENWICH ST
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10013
		BUSINESS PHONE:		212-816-6000

	MAIL ADDRESS:	
		STREET 1:		388 GREENWICH ST
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10013

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CITIGROUP GLOBAL MARKETS HOLDINGS INC
		DATE OF NAME CHANGE:	20030404

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SALOMON SMITH BARNEY HOLDINGS INC
		DATE OF NAME CHANGE:	19971128

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SALOMON INC
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B2
<SEQUENCE>1
<FILENAME>dp235444_424b2-us2514716.htm
<DESCRIPTION>PRICING SUPPLEMENT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: center; font-size: 10pt; color: red">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap; width: 53%; font-size: 10pt; color: #888888"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD>
    <TD STYLE="white-space: nowrap; width: 47%">
    <P STYLE="color: gray; font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right">September 30, 2025</P>
    <P STYLE="color: gray; font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right">Medium-Term Senior Notes, Series
    N</P>
    <P STYLE="color: gray; font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right">Pricing Supplement No. 2025-USNCH28642</P>
    <P STYLE="color: gray; font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right">Filed Pursuant to Rule 424(b)(2)</P>
    <P STYLE="color: gray; font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right">Registration Statement Nos. 333-270327
    and 333-270327-01</P></TD></TR>
  </TABLE>
<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; color: rgb(89,174,67); margin: 0pt 0">Autocallable Contingent Coupon Equity Linked Securities
Linked to the Worst Performing of Novo Nordisk A/S and Oracle Corporation Due October 5, 2028</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 9.35pt"><FONT STYLE="font-size: 10pt">&squarf;</FONT></TD><TD>The securities offered by this pricing supplement are unsecured debt securities issued by Citigroup Global Markets Holdings Inc. and
guaranteed by Citigroup Inc. The securities offer the potential for periodic contingent coupon payments at an annualized rate that, if
all are paid, would produce a yield that is generally higher than the yield on our conventional debt securities of the same maturity.
In exchange for this higher potential yield, you must be willing to accept the risks that (i) your actual yield may be lower than the
yield on our conventional debt securities of the same maturity because you may not receive one or more, or any, contingent coupon payments,
(ii) the value of what you receive at maturity may be significantly less than the stated principal amount of your securities, and may
be zero, and (iii) the securities may be automatically called for redemption prior to maturity beginning on the first potential autocall
date specified below. Each of these risks will depend solely on the performance of the <B>worst performing</B> of the underlyings specified
below.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 9.35pt"><FONT STYLE="font-size: 10pt">&squarf;</FONT></TD><TD>You will be subject to risks associated with <U>each</U> of the underlyings and will be negatively affected by adverse movements in
<U>any one</U> of the underlyings. Although you will have downside exposure to the worst performing underlying, you will not receive dividends
with respect to any underlying or participate in any appreciation of any underlying.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 9.35pt"><FONT STYLE="font-size: 10pt">&squarf;</FONT></TD><TD>Investors in the securities must be willing to accept (i) an investment that may have limited or no liquidity and (ii) the risk of
not receiving any payments due under the securities if we and Citigroup Inc. default on our obligations. <B>All payments on the securities
are subject to the credit risk of Citigroup Global Markets Holdings Inc. and Citigroup Inc.</B></TD></TR></TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #59AE43">
    <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="color: white"><B>KEY TERMS</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 19%; font-size: 10pt"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Issuer:</B></FONT></TD>
    <TD STYLE="width: 81%; font-size: 10pt"><FONT STYLE="font-size: 10pt">Citigroup Global Markets Holdings Inc., a wholly owned subsidiary of Citigroup Inc.</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #EAF3E5">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Guarantee:</B></FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">All payments due on the securities are fully and unconditionally guaranteed by Citigroup Inc.</FONT></TD></TR>
  </TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="width: 19%; border-right: #59AE43 1pt solid"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Underlyings:</B></FONT></TD>
    <TD STYLE="width: 11%; border-top: #59AE43 1pt solid; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Underlying</B></FONT></TD>
    <TD STYLE="width: 14%; border-top: #59AE43 1pt solid; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Initial underlying value</B></FONT><B><FONT STYLE="color: #59AE43"><SUP>*</SUP></FONT></B></TD>
    <TD STYLE="width: 14%; border-top: #59AE43 1pt solid; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Coupon barrier value</B></FONT><B><FONT STYLE="color: #59AE43"><SUP>**</SUP></FONT></B></TD>
    <TD STYLE="width: 14%; border-top: #59AE43 1pt solid; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Autocall barrier value</B></FONT><B><FONT STYLE="color: #59AE43"><SUP>***</SUP></FONT></B></TD>
    <TD STYLE="width: 14%; border-top: #59AE43 1pt solid; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Final barrier value</B></FONT><B><FONT STYLE="color: #59AE43"><SUP>****</SUP></FONT></B></TD>
    <TD STYLE="width: 14%; border-top: #59AE43 1pt solid; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Equity ratio</B></FONT><B><FONT STYLE="color: #59AE43"><SUP>*****</SUP></FONT></B></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; border-right: #59AE43 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">Novo Nordisk A/S</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$55.49</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$38.843</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$44.392</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$33.294</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">18.02127</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; border-right: #59AE43 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">Oracle Corporation</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$281.24</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$196.868</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$224.992</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$168.744</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">3.55568</FONT></TD></TR>
  </TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 19%">&nbsp;</TD>
    <TD STYLE="width: 81%">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><SUP>*</SUP>For each underlying, its closing value on the pricing date</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><SUP>**</SUP>For each underlying, 70.00% of its initial underlying value</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><SUP>***</SUP>For each underlying, 80.00% of its initial underlying
    value</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><SUP>****</SUP>For each underlying, 60.00% of its initial underlying
    value</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><SUP>*****</SUP>For each underlying, the stated principal amount <I>divided
    by</I> its initial underlying value</P></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #EAF3E5">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Stated principal amount:</B></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">$1,000 per security</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Pricing date:</B></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">September 30, 2025</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #EAF3E5">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Issue date:</B></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">October 3, 2025</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Valuation dates:</B></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">December 30, 2025, March 30, 2026, June 30, 2026, September 30, 2026, December 30, 2026, March 30, 2027, June 30, 2027, September 30, 2027, December 30, 2027, March 30, 2028, June 30, 2028 and October 2, 2028 (the &ldquo;final valuation date&rdquo;), each subject to postponement if such date is not a scheduled trading day or certain market disruption events occur</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #EAF3E5">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Maturity date:</B></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Unless earlier redeemed, October 5, 2028</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Contingent coupon payment dates:</B></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">The third business day after each valuation date, except that the contingent coupon payment date following the final valuation date will be the maturity date</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #EAF3E5">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Contingent coupon:</B></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">On each contingent coupon payment date, unless previously redeemed, the securities will pay a contingent coupon equal to 5.3125% of the stated principal amount of the securities (equivalent to a contingent coupon rate of 21.25% per annum) <B>if and only if</B> the closing value of the worst performing underlying on the immediately preceding valuation date is greater than or equal to its coupon barrier value. <B>If the closing value of the worst performing underlying on any valuation date is less than its coupon barrier value, you will not receive any contingent coupon payment on the immediately following contingent coupon payment date. </B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Payment at maturity:</B></FONT></TD>
    <TD>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">If the securities are not automatically redeemed prior to maturity,
    you will receive at maturity for each security you then hold (in addition to the final contingent coupon payment, if applicable):</P>
    <P STYLE="font: 10pt Wingdings; margin: 0pt 0 0pt 26.35pt; text-indent: -8.5pt">&sect;</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: -11pt 0pt 0pt 0.4in; text-indent: 0in">If the final underlying value of the worst
    performing underlying on the final valuation date is <B>greater than or equal to</B> its final barrier value: $1,000</P>
    <P STYLE="font: 10pt Wingdings; margin: 0pt 0 0pt 26.35pt; text-indent: -8.5pt">&sect;</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: -11pt 0pt 0pt 0.4in; text-indent: 0in">If the final underlying value of the worst
    performing underlying on the final valuation date is <B>less than</B> its final barrier value:</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.4in; text-indent: 0in">a fixed number of underlying shares of the
    worst performing underlying on the final valuation date equal to its equity ratio (or, if we elect, the cash value of those shares based
    on its final underlying value)</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>If the securities are not automatically redeemed prior to maturity
    and the final underlying value of the worst performing underlying on the final valuation date is less than its final barrier value, you
    will receive underlying shares of the worst performing underlying on the final valuation date (or, in our sole discretion, cash) that
    will be worth significantly less than the stated principal amount of your securities, and possibly nothing, at maturity, and you will
    not receive any contingent coupon payment at maturity.</B></P></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #EAF3E5">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Listing:</B></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">The securities will not be listed on any securities exchange</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Underwriter:</B></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Citigroup Global Markets Inc. (&ldquo;<B>CGMI</B>&rdquo;), an affiliate of the issuer, acting as principal</FONT></TD></TR>
  </TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #EAF3E5">
    <TD STYLE="width: 19%"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Underwriting fee and issue price:</B></FONT></TD>
    <TD STYLE="width: 26%; text-align: center"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Issue price<SUP>(1)</SUP></B></FONT></TD>
    <TD STYLE="width: 29%; text-align: center"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Underwriting fee<SUP>(2)</SUP></B></FONT></TD>
    <TD STYLE="width: 26%; text-align: center"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Proceeds to issuer</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Per security:</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">$1,000.00</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">$35.00</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">$965.00</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #EAF3E5">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Total:</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">$521,000.00</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">$18,235.00</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">$502,765.00</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right"><I>(Key Terms continued on next page)</I></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">(1) On the date of this pricing supplement, the estimated value of the
securities is $941.90 per security, which is less than the issue price. The estimated value of the securities is based on CGMI&rsquo;s
proprietary pricing models and our internal funding rate. It is not an indication of actual profit to CGMI or other of our affiliates,
nor is it an indication of the price, if any, at which CGMI or any other person may be willing to buy the securities from you at any time
after issuance. See &ldquo;Valuation of the Securities&rdquo; in this pricing supplement.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">(2) For more information on the distribution of the securities, see
&ldquo;Supplemental Plan of Distribution&rdquo; in this pricing supplement. In addition to the underwriting fee, CGMI and its affiliates
may profit from hedging activity related to this offering, even if the value of the securities declines. See &ldquo;Use of Proceeds and
Hedging&rdquo; in the accompanying prospectus.</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Investing in the securities involves risks not associated with an
investment in conventional debt securities. See &ldquo;Summary Risk Factors&rdquo; beginning on page PS-6.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B>Neither the Securities and Exchange Commission
nor any state securities commission has approved or disapproved of the securities or determined that this pricing supplement and the accompanying
product supplement, prospectus supplement and prospectus are truthful or complete. Any representation to the contrary is a criminal offense.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B><I>You should read this pricing supplement together
with the accompanying product supplement, prospectus supplement and prospectus, which can be accessed via the hyperlinks below:</I></B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; text-align: center"><A HREF="https://www.sec.gov/Archives/edgar/data/200245/000095010323003814/dp190219_424b2-coba0410.htm" STYLE="color: rgb(89,174,67); text-decoration: underline"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Product Supplement No. EA-04-10 dated March 7, 2023</B></FONT></A></TD>
    <TD STYLE="width: 50%; text-align: center"><A HREF="https://www.sec.gov/Archives/edgar/data/831001/000119312523063080/d470905d424b2.htm" STYLE="color: rgb(89,174,67); text-decoration: underline"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Prospectus Supplement and Prospectus each dated March 7, 2023</B></FONT></A></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B>The securities are not bank deposits and are
not insured or guaranteed by the Federal Deposit Insurance Corporation or any other governmental agency, nor are they obligations of,
or guaranteed by, a bank.</B></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="border-bottom: #59AE40 1pt solid; width: 100%; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="padding: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #59AE43">
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt; color: white"><B>KEY TERMS (continued)</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 23%"><FONT STYLE="color: #59AE43"><B>Automatic early redemption:</B></FONT></TD>
    <TD STYLE="width: 77%">If, on any potential autocall date, the closing value of the worst performing underlying on that potential autocall date is greater than or equal to its autocall barrier value, each security you then hold will be automatically called on that potential autocall date for redemption on the immediately following contingent coupon payment date for an amount in cash equal to $1,000 <I>plus</I> the related contingent coupon payment. <B>The automatic early redemption feature may significantly limit your potential return on the securities. If the worst performing underlying performs in a way that would otherwise be favorable, the securities are likely to be automatically called for redemption prior to maturity, cutting short your opportunity to receive contingent coupon payments. The securities may be automatically called for redemption as early as the first potential autocall date specified below.</B></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #EAF3E5">
    <TD><FONT STYLE="color: #59AE43"><B>Potential autocall dates:</B></FONT></TD>
    <TD>The valuation dates scheduled to occur on March 30, 2026, June 30, 2026, September 30, 2026, December 30, 2026, March 30, 2027, June 30, 2027, September 30, 2027, December 30, 2027, March 30, 2028 and June 30, 2028</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="color: #59AE43"><B>Final underlying value:</B></FONT></TD>
    <TD>For each underlying, its closing value on the final valuation date</TD></TR>
  <TR STYLE="vertical-align: top; background-color: #EAF3E5">
    <TD><FONT STYLE="color: #59AE43"><B>Worst performing underlying:</B></FONT></TD>
    <TD>For any valuation date, the underlying with the lowest underlying return determined as of that valuation date</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="color: #59AE43"><B>Underlying return:</B></FONT></TD>
    <TD>For each underlying on any valuation date, (i) its closing value on that valuation date <I>minus</I> its initial underlying value, <I>divided by</I> (ii) its initial underlying value</TD></TR>
  <TR STYLE="vertical-align: top; background-color: #EAF3E5">
    <TD><FONT STYLE="color: #59AE43"><B>CUSIP / ISIN:</B></FONT></TD>
    <TD>17333MRU9 / US17333MRU98</TD></TR>
  </TABLE>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="border-bottom: #59AE40 1pt solid; width: 100%; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="padding: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">Additional Information</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>General.</B> The terms of the securities are set forth in the accompanying
product supplement, prospectus supplement and prospectus, as supplemented by this pricing supplement. The accompanying product supplement,
prospectus supplement and prospectus contain important disclosures that are not repeated in this pricing supplement. For example, the
accompanying product supplement contains important information about how the closing value of each underlying will be determined and about
adjustments that may be made to the terms of the securities upon the occurrence of market disruption events and other specified events
with respect to each underlying. It is important that you read the accompanying product supplement, prospectus supplement and prospectus
together with this pricing supplement in connection with your investment in the securities. Certain terms used but not defined in this
pricing supplement are defined in the accompanying product supplement.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Closing Value.</B> The &ldquo;closing value&rdquo; of each underlying
on any date is the closing price of its underlying shares on such date, as provided in the accompanying product supplement. The &ldquo;underlying
shares&rdquo; of (i) Oracle Corporation are its shares of common stock and (ii) Novo Nordisk A/S are American Depositary Shares (&ldquo;ADSs&rdquo;)
representing its B shares. Please see the accompanying product supplement for more information.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="border-bottom: #59AE40 1pt solid; width: 100%; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="padding: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">Hypothetical Examples</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The examples in the first section below illustrate how to determine
whether a contingent coupon will be paid and whether the securities will be automatically called for redemption following a valuation
date that is also a potential autocall date. The examples in the second section below illustrate how to determine the payment at maturity
on the securities, assuming the securities are not automatically redeemed prior to maturity. The examples are solely for illustrative
purposes, do not show all possible outcomes and are not a prediction of any payment that may be made on the securities.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The examples below are based on the following hypothetical values and
do not reflect the actual initial underlying values, coupon barrier values, final barrier values, autocall barrier values or equity ratios
of the underlyings. For the actual initial underlying value, coupon barrier value, final barrier value, autocall barrier value and equity
ratio of each underlying, see the cover page of this pricing supplement. We have used these hypothetical values, rather than the actual
values, to simplify the calculations and aid understanding of how the securities work. However, you should understand that the actual
payments on the securities will be calculated based on the actual initial underlying value, coupon barrier value, final barrier value,
autocall barrier value and equity ratio of each underlying, and not the hypothetical values indicated below. For ease of analysis, figures
below have been rounded.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="4" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="width: 20%; border: #59AE43 1pt solid; text-align: center"><FONT STYLE="color: #59AE43"><B>Underlying</B></FONT></TD>
    <TD STYLE="width: 16%; border-top: #59AE43 1pt solid; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="color: #59AE43"><B>Hypothetical initial <BR>
underlying value</B></FONT></TD>
    <TD STYLE="width: 16%; border-top: #59AE43 1pt solid; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="color: #59AE43"><B>Hypothetical coupon <BR>
barrier value</B></FONT></TD>
    <TD STYLE="width: 16%; border-top: #59AE43 1pt solid; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="color: #59AE43"><B>Hypothetical final <BR>
barrier value</B></FONT></TD>
    <TD STYLE="width: 16%; border-top: #59AE43 1pt solid; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="color: #59AE43"><B>Hypothetical autocall <BR>
barrier value</B></FONT></TD>
    <TD STYLE="width: 16%; border-top: #59AE43 1pt solid; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="color: #59AE43"><B>Hypothetical equity <BR>
ratio</B></FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; border-left: #59AE43 1pt solid; text-align: center">Novo Nordisk A/S</TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center">$100.00</TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center">$70.00 (70.00% of its hypothetical initial underlying value)</TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center">$60.00 (60.00% of its hypothetical initial underlying value)</TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center">$80.00 (80.00% of its hypothetical initial underlying value)</TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center">10.00000</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; border-left: #59AE43 1pt solid; text-align: center">Oracle Corporation</TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center">$100.00</TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center">$70.00 (70.00% of its hypothetical initial underlying value)</TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center">$60.00 (60.00% of its hypothetical initial underlying value)</TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center">$80.00 (80.00% of its hypothetical initial underlying value)</TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center">10.00000</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43"><B><I>Hypothetical Examples of Contingent Coupon Payments
and any Payment upon Automatic Early Redemption Following a Valuation Date that is also a Potential Autocall Date</I></B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The three hypothetical examples below illustrate how to determine whether
a contingent coupon will be paid and whether the securities will be automatically redeemed following a hypothetical valuation date that
is also a potential autocall date, assuming that the closing values of the underlyings on the hypothetical valuation date are as indicated
below.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="4" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 25%; border: #59AE43 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 25%; border-top: #59AE43 1pt solid; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><B>Hypothetical closing value of Novo <FONT STYLE="color: #59AE43"><BR>
</FONT>Nordisk A/S on hypothetical <FONT STYLE="color: #59AE43"><BR>
</FONT>valuation date</B></TD>
    <TD STYLE="width: 25%; border-top: #59AE43 1pt solid; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><B>Hypothetical closing value of Oracle <FONT STYLE="color: #59AE43"><BR>
</FONT>Corporation on hypothetical <FONT STYLE="color: #59AE43"><BR>
</FONT>valuation date</B></TD>
    <TD STYLE="width: 25%; border-top: #59AE43 1pt solid; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><B>Hypothetical payment per $1,000.00 <FONT STYLE="color: #59AE43"><BR>
</FONT>security on related contingent <FONT STYLE="color: #59AE43"><BR>
</FONT>coupon payment date</B></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; border-left: #59AE43 1pt solid; text-align: center"><FONT STYLE="color: #59AE43"><B>Example 1</B></FONT></TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center">$120<BR>
(underlying return =<BR>
($120 - $100) / $100 = 20%)</TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center">$75<BR>
(underlying return =<BR>
($75 - $100) / $100 = -25%)</TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><B>$53.125</B><BR>
(contingent coupon is paid; securities not redeemed)</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; border-left: #59AE43 1pt solid; text-align: center"><FONT STYLE="color: #59AE43"><B>Example 2</B></FONT></TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center">$45<BR>
(underlying return =<BR>
($45 - $100) / $100 = -55%)</TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center">$120<BR>
(underlying return =<BR>
($120 - $100) / $100 = 20%)</TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><B>$0.00</B><BR>
(no contingent coupon; securities not redeemed)</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; border-left: #59AE43 1pt solid; text-align: center"><FONT STYLE="color: #59AE43"><B>Example 3</B></FONT></TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center">$110<BR>
(underlying return =<BR>
($110 - $100) / $100 = 10%)</TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center">$115<BR>
(underlying return =<BR>
($115 - $100) / $100 = 15%)</TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><B>$1,053.125</B><BR>
(contingent coupon is paid; securities redeemed)</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="color: #59AE43"><B>Example 1:</B></FONT> On the hypothetical
valuation date, Oracle Corporation has the lowest underlying return and, therefore, is the worst performing underlying on the hypothetical
valuation date. In this scenario, the closing value of the worst performing underlying on the hypothetical valuation date is greater than
its coupon barrier value but less than its autocall barrier value. As a result, investors in the securities would receive the contingent
coupon payment on the related contingent coupon payment date and the securities would not be automatically redeemed.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="color: #59AE43"><B>Example 2:</B></FONT> On the hypothetical
valuation date, Novo Nordisk A/S has the lowest underlying return and, therefore, is the worst performing underlying on the hypothetical
valuation date. In this scenario, the closing value of the worst performing underlying on the hypothetical valuation date is less than
its coupon barrier value. As a result, investors would not receive any payment on the related contingent coupon payment date and the securities
would not be automatically redeemed.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Investors in the securities will not receive a contingent coupon
on the contingent coupon payment date following a valuation date if the closing value of the worst performing underlying on that valuation
date is less than its coupon barrier value. Whether a contingent coupon is paid following a valuation date depends solely on the closing
value of the worst performing underlying on that valuation date.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="color: #59AE43"><B>Example 3:</B></FONT> On the hypothetical
valuation date, Novo Nordisk A/S has the lowest underlying return and, therefore, is the worst performing underlying on the hypothetical
valuation date. In this scenario, the closing value of the worst performing underlying on the hypothetical valuation date is greater than
both its coupon barrier value and its autocall barrier value. As a result, the securities would be automatically redeemed on the related
contingent coupon payment date for an amount in cash equal to $1,000.00 <I>plus</I> the related contingent coupon payment.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">If the hypothetical valuation date were not also a potential autocall
date, the securities would not be automatically redeemed on the related contingent coupon payment date.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="border-bottom: #59AE40 1pt solid; width: 100%; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="padding: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43"><B><I>Hypothetical Examples of the Payment at Maturity
on the Securities</I></B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The next four hypothetical examples illustrate the calculation of the
payment at maturity on the securities, assuming that the securities have not been earlier automatically redeemed and that the final underlying
values of the underlyings are as indicated below.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="4" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 25%; border: #59AE43 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 25%; border-top: #59AE43 1pt solid; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><B>Hypothetical final underlying value <FONT STYLE="color: #59AE43"><BR>
</FONT>of Novo Nordisk A/S</B></TD>
    <TD STYLE="width: 25%; border-top: #59AE43 1pt solid; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><B>Hypothetical final underlying value <FONT STYLE="color: #59AE43"><BR>
</FONT>of Oracle Corporation</B></TD>
    <TD STYLE="width: 25%; border-top: #59AE43 1pt solid; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><B>Hypothetical payment at maturity <FONT STYLE="color: #59AE43"><BR>
</FONT>per $1,000.00 security</B></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; border-left: #59AE43 1pt solid; text-align: center"><FONT STYLE="color: #59AE43"><B>Example 4</B></FONT></TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center">$110<BR>
(underlying return =<BR>
($110 - $100) / $100 = 10%)</TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center">$120<BR>
(underlying return =<BR>
($120 - $100) / $100 = 20%)</TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><B>$1,053.125</B><BR>
(contingent coupon is paid)</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; border-left: #59AE43 1pt solid; text-align: center"><FONT STYLE="color: #59AE43"><B>Example 5</B></FONT></TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center">$130<BR>
(underlying return =<BR>
($130 - $100) / $100 = 30%)</TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center">$65<BR>
(underlying return =<BR>
($65 - $100) / $100 = -35%)</TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><B>$1,000.00</B></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; border-left: #59AE43 1pt solid; text-align: center"><FONT STYLE="color: #59AE43"><B>Example 6</B></FONT></TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center">$110<BR>
(underlying return =<BR>
($110 - $100) / $100 = 10%)</TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center">$50<BR>
(underlying return =<BR>
($50 - $100) / $100 = -50%)</TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><B>A number of underlying shares of the worst performing underlying on the final valuation date (or, in our sole discretion, cash) worth $500.00 based on its final underlying value</B></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; border-left: #59AE43 1pt solid; text-align: center"><FONT STYLE="color: #59AE43"><B>Example 7</B></FONT></TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center">$0<BR>
(underlying return =<BR>
($0 - $100) / $100 = -100%)</TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center">$60<BR>
(underlying return =<BR>
($60 - $100) / $100 = -40%)</TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><B>$0.00</B></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="color: #59AE43"><B>Example 4:</B></FONT> On the final valuation
date, Novo Nordisk A/S has the lowest underlying return and, therefore, is the worst performing underlying on the final valuation date.
In this scenario, the final underlying value of the worst performing underlying on the final valuation date is greater than its final
barrier value and its coupon barrier value. Accordingly, at maturity, you would receive the stated principal amount of the securities
<I>plus</I> the contingent coupon payment due at maturity, but you would not participate in the appreciation of any of the underlyings.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="color: #59AE43"><B>Example 5:</B></FONT> On the final valuation
date, Oracle Corporation has the lowest underlying return and, therefore, is the worst performing underlying on the final valuation date.
In this scenario, the final underlying value of the worst performing underlying on the final valuation date is less than its coupon barrier
value but greater than its final barrier value. Accordingly, at maturity, you would receive the stated principal amount of the securities,
but would not receive any contingent coupon payment at maturity.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="color: #59AE43"><B>Example 6:</B></FONT> On the final valuation
date, Oracle Corporation has the lowest underlying return and, therefore, is the worst performing underlying on the final valuation date.
In this scenario, the final underlying value of the worst performing underlying on the final valuation date is less than its final barrier
value. Accordingly, at maturity, you would receive for each security you then hold a fixed number of underlying shares of the worst performing
underlying on the final valuation date equal to its equity ratio (or, at our option, the cash value thereof).</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">In this scenario, the value of a number of underlying shares of the
worst performing underlying on the final valuation date equal to its equity ratio, based on its final underlying value, would be $500.00.
Therefore, the value of the underlying shares of the worst performing underlying on the final valuation date (or, in our discretion, cash)
you receive at maturity would be significantly less than the stated principal amount of your securities. You would incur a loss based
on the depreciation of the worst performing underlying on the final valuation date. In addition, because the final underlying value of
the worst performing underlying on the final valuation date is below its coupon barrier value, you would not receive any contingent coupon
payment at maturity.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">If the final underlying value of the worst performing underlying on
the final valuation date is less than its final barrier value, we will have the option to deliver to you on the maturity date either a
number of underlying shares of the worst performing underlying on the final valuation date equal to its equity ratio or the cash value
of those underlying shares based on their final underlying value. The value of those underlying shares on the maturity date may be different
than their final underlying value.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="color: #59AE43"><B>Example 7:</B></FONT> On the final valuation
date, Novo Nordisk A/S has the lowest underlying return and, therefore, is the worst performing underlying on the final valuation date.
In this scenario, the underlying shares of the worst performing underlying on the final valuation date are worthless and you would lose
your entire investment in the securities at maturity. In addition, because the final underlying value of the worst performing underlying
on the final valuation date is below its coupon barrier value, you would not receive any contingent coupon payment at maturity.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>It is possible that the closing value of the worst performing underlying
will be less than its coupon barrier value on each valuation date and less than its final barrier value on the final valuation date, such
that you will not receive any contingent coupon payments over the term of the securities and will receive significantly less than the
stated principal amount of your securities, and possibly nothing, at maturity.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="border-bottom: #59AE40 1pt solid; width: 100%; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="padding: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">Summary Risk Factors</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">An investment in the securities is significantly riskier than an investment
in conventional debt securities. The securities are subject to all of the risks associated with an investment in our conventional debt
securities (guaranteed by Citigroup Inc.), including the risk that we and Citigroup Inc. may default on our obligations under the securities,
and are also subject to risks associated with each underlying. Accordingly, the securities are suitable only for investors who are capable
of understanding the complexities and risks of the securities. You should consult your own financial, tax and legal advisors as to the
risks of an investment in the securities and the suitability of the securities in light of your particular circumstances.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The following is a summary of certain key risk factors for investors
in the securities. You should read this summary together with the more detailed description of risks relating to an investment in the
securities contained in the section &ldquo;Risk Factors Relating to the Securities&rdquo; beginning on page EA-7 in the accompanying product
supplement. You should also carefully read the risk factors included in the accompanying prospectus supplement and in the documents incorporated
by reference in the accompanying prospectus, including Citigroup Inc.&rsquo;s most recent Annual Report on Form 10-K and any subsequent
Quarterly Reports on Form 10-Q, which describe risks relating to the business of Citigroup Inc. more generally.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>You may lose a significant portion or all of your investment.</B> Unlike conventional debt securities, the securities do not provide
for the repayment of the stated principal amount at maturity in all circumstances. If the securities are not automatically redeemed prior
to maturity, your payment at maturity will depend on the final underlying value of the worst performing underlying on the final valuation
date. If the final underlying value of the worst performing underlying on the final valuation date is less than its final barrier value,
you will not receive the stated principal amount of your securities at maturity and, instead, will receive underlying shares of the worst
performing underlying on the final valuation date (or, in our sole discretion, cash based on its final underlying value) that will be
worth significantly less than the stated principal amount and possibly nothing. There is no minimum payment at maturity on the securities,
and you may lose up to all of your investment.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">We may elect, in our sole discretion, to pay you cash at maturity
in lieu of delivering any underlying shares of the worst performing underlying on the final valuation date. If we elect to pay you cash
at maturity in lieu of delivering any underlying shares, the amount of that cash may be less than the market value of the underlying shares
on the maturity date because the market value will likely fluctuate between the final valuation date and the maturity date. Conversely,
if we do not exercise our cash election right and instead deliver underlying shares of the worst performing underlying on the final valuation
date to you on the maturity date, the market value of such underlying shares may be less than the cash amount you would have received
if we had exercised our cash election right. We will have no obligation to take your interests into account when deciding whether to exercise
our cash election right.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>You will not receive any contingent coupon on the contingent coupon payment date following any valuation date on which the closing
value of the worst performing underlying on that valuation date is less than its coupon barrier value.</B> A contingent coupon payment
will be made on a contingent coupon payment date if and only if the closing value of the worst performing underlying on the immediately
preceding valuation date is greater than or equal to its coupon barrier value. If the closing value of the worst performing underlying
on any valuation date is less than its coupon barrier value, you will not receive any contingent coupon payment on the immediately following
contingent coupon payment date. If the closing value of the worst performing underlying on each valuation date is below its coupon barrier
value, you will not receive any contingent coupon payments over the term of the securities.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>Higher contingent coupon rates are associated with greater risk.</B> The securities offer contingent coupon payments at an annualized
rate that, if all are paid, would produce a yield that is generally higher than the yield on our conventional debt securities of the same
maturity. This higher potential yield is associated with greater levels of expected risk as of the pricing date for the securities, including
the risk that you may not receive a contingent coupon payment on one or more, or any, contingent coupon payment dates and the risk that
the value of what you receive at maturity may be significantly less than the stated principal amount of your securities and may be zero.
The volatility of, and correlation between, the closing values of the underlyings are important factors affecting these risks. Greater
expected volatility of, and lower expected correlation between, the closing values of the underlyings as of the pricing date may result
in a higher contingent coupon rate, but would also represent a greater expected likelihood as of the pricing date that the closing value
of the worst performing underlying on one or more valuation dates will be less than its coupon barrier value, such that you will not receive
one or more, or any, contingent coupon payments during the term of the securities and that the final underlying value of the worst performing
underlying on the final valuation date will be less than its final barrier value, such that you will not be repaid the stated principal
amount of your securities at maturity.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The securities are subject to heightened risk because they have multiple underlyings.</B> The securities are more risky than similar
investments that may be available with only one underlying. With multiple underlyings, there is a greater chance that any one underlying
will perform poorly, adversely affecting your return on the securities.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The securities are subject to the risks of each of the underlyings and will be negatively affected if any one underlying performs
poorly.</B> You are subject to risks associated with each of the underlyings. If any one underlying performs poorly, you will be negatively
affected. The securities are not linked to a basket composed of the underlyings, where the blended performance of the underlyings would
be better than the performance of the worst performing underlying alone. Instead, you are subject to the full risks of whichever of the
underlyings is the worst performing underlying.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>You will not benefit in any way from the performance of any better performing underlying.</B> The return on the securities depends
solely on the performance of the worst performing underlying, and you will not benefit in any way from the performance of any better performing
underlying.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>You will be subject to risks relating to the relationship between the underlyings.</B> It is preferable from your perspective for
the underlyings to be correlated with each other, in the sense that their closing values tend to increase or decrease at similar times
and by similar magnitudes. By investing in the securities, you assume the risk that the underlyings will not exhibit this relationship.
The less</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="border-bottom: #59AE40 1pt solid; width: 100%; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="padding: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">correlated the underlyings, the more likely
it is that any one of the underlyings will perform poorly over the term of the securities. All that is necessary for the securities to
perform poorly is for one of the underlyings to perform poorly. It is impossible to predict what the relationship between the underlyings
will be over the term of the securities. The underlyings differ in significant ways and, therefore, may not be correlated with each other.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>You may not be adequately compensated for assuming the downside risk of the worst performing underlying.</B> The potential contingent
coupon payments on the securities are the compensation you receive for assuming the downside risk of the worst performing underlying,
as well as all the other risks of the securities. That compensation is effectively &ldquo;at risk&rdquo; and may, therefore, be less than
you currently anticipate. First, the actual yield you realize on the securities could be lower than you anticipate because the coupon
is &ldquo;contingent&rdquo; and you may not receive a contingent coupon payment on one or more, or any, of the contingent coupon payment
dates. Second, the contingent coupon payments are the compensation you receive not only for the downside risk of the worst performing
underlying, but also for all of the other risks of the securities, including the risk that the securities may be automatically redeemed
prior to maturity, interest rate risk and our and Citigroup Inc.&rsquo;s credit risk. If those other risks increase or are otherwise greater
than you currently anticipate, the contingent coupon payments may turn out to be inadequate to compensate you for all the risks of the
securities, including the downside risk of the worst performing underlying.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The securities may be automatically redeemed prior to maturity, limiting your opportunity to receive contingent coupon payments.</B>
On any potential autocall date, the securities will be automatically called for redemption if the closing value of the worst performing
underlying on that potential autocall date is greater than or equal to its autocall barrier value. As a result, if the worst performing
underlying performs in a way that would otherwise be favorable, the securities are likely to be automatically redeemed, cutting short
your opportunity to receive contingent coupon payments. If the securities are automatically redeemed prior to maturity, you may not be
able to reinvest your funds in another investment that provides a similar yield with a similar level of risk.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The securities offer downside exposure to the worst performing underlying, but no upside exposure to any underlying.</B> You will
not participate in any appreciation in the value of any underlying over the term of the securities. Consequently, your return on the securities
will be limited to the contingent coupon payments you receive, if any, and may be significantly less than the return on any underlying
over the term of the securities. In addition, as an investor in the securities, you will not receive any dividends or other distributions
or have any other rights with respect to any of the underlyings.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The performance of the securities will depend on the closing values of the underlyings solely on the valuation dates, which makes
the securities particularly sensitive to volatility in the closing values of the underlyings on or near the valuation dates.</B> Whether
the contingent coupon will be paid on any given contingent coupon payment date and whether the securities will be automatically redeemed
prior to maturity will depend on the closing values of the underlyings solely on the applicable valuation dates, regardless of the closing
values of the underlyings on other days during the term of the securities. If the securities are not automatically redeemed prior to maturity,
what you receive at maturity will depend solely on the closing value of the worst performing underlying on the final valuation date, and
not on any other day during the term of the securities. Because the performance of the securities depends on the closing values of the
underlyings on a limited number of dates, the securities will be particularly sensitive to volatility in the closing values of the underlyings
on or near the valuation dates. You should understand that the closing value of each underlying has historically been highly volatile.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The securities are subject to the credit risk of Citigroup Global Markets Holdings Inc. and Citigroup Inc.</B> If we default on
our obligations under the securities and Citigroup Inc. defaults on its guarantee obligations, you may not receive anything owed to you
under the securities.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The securities will not be listed on any securities exchange and you may not be able to sell them prior to maturity.</B> The securities
will not be listed on any securities exchange. Therefore, there may be little or no secondary market for the securities. CGMI currently
intends to make a secondary market in relation to the securities and to provide an indicative bid price for the securities on a daily
basis. Any indicative bid price for the securities provided by CGMI will be determined in CGMI&rsquo;s sole discretion, taking into account
prevailing market conditions and other relevant factors, and will not be a representation by CGMI that the securities can be sold at that
price, or at all. CGMI may suspend or terminate making a market and providing indicative bid prices without notice, at any time and for
any reason. If CGMI suspends or terminates making a market, there may be no secondary market at all for the securities because it is likely
that CGMI will be the only broker-dealer that is willing to buy your securities prior to maturity. Accordingly, an investor must be prepared
to hold the securities until maturity.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The estimated value of the securities on the pricing date, based on CGMI&rsquo;s proprietary pricing models and our internal funding
rate, is less than the issue price.</B> The difference is attributable to certain costs associated with selling, structuring and hedging
the securities that are included in the issue price. These costs include (i) any selling concessions or other fees paid in connection
with the offering of the securities, (ii) hedging and other costs incurred by us and our affiliates in connection with the offering of
the securities and (iii) the expected profit (which may be more or less than actual profit) to CGMI or other of our affiliates in connection
with hedging our obligations under the securities. These costs adversely affect the economic terms of the securities because, if they
were lower, the economic terms of the securities would be more favorable to you. The economic terms of the securities are also likely
to be adversely affected by the use of our internal funding rate, rather than our secondary market rate, to price the securities. See
&ldquo;The estimated value of the securities would be lower if it were calculated based on our secondary market rate&rdquo; below.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The estimated value of the securities was determined for us by our affiliate using proprietary pricing models.</B> CGMI derived
the estimated value disclosed on the cover page of this pricing supplement from its proprietary pricing models. In doing so, it may have
made discretionary judgments about the inputs to its models, such as the volatility of, and correlation between, the closing values of
the underlyings, dividend yields on the underlyings and interest rates. CGMI&rsquo;s views on these inputs may differ from your or others&rsquo;
views, and as an underwriter in this offering, CGMI&rsquo;s interests may conflict with yours. Both the models and the inputs to the models
may prove to be wrong and therefore not an accurate reflection of the value of the securities. Moreover, the estimated value of the securities
set</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="border-bottom: #59AE40 1pt solid; width: 100%; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="padding: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">forth on the cover page of this pricing
supplement may differ from the value that we or our affiliates may determine for the securities for other purposes, including for accounting
purposes. You should not invest in the securities because of the estimated value of the securities. Instead, you should be willing to
hold the securities to maturity irrespective of the initial estimated value.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The estimated value of the securities would be lower if it were calculated based on our secondary market rate.</B> The estimated
value of the securities included in this pricing supplement is calculated based on our internal funding rate, which is the rate at which
we are willing to borrow funds through the issuance of the securities. Our internal funding rate is generally lower than our secondary
market rate, which is the rate that CGMI will use in determining the value of the securities for purposes of any purchases of the securities
from you in the secondary market. If the estimated value included in this pricing supplement were based on our secondary market rate,
rather than our internal funding rate, it would likely be lower. We determine our internal funding rate based on factors such as the costs
associated with the securities, which are generally higher than the costs associated with conventional debt securities, and our liquidity
needs and preferences. Our internal funding rate is not an interest rate that is payable on the securities.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">Because there is not an active market for traded instruments
referencing our outstanding debt obligations, CGMI determines our secondary market rate based on the market price of traded instruments
referencing the debt obligations of Citigroup Inc., our parent company and the guarantor of all payments due on the securities, but subject
to adjustments that CGMI makes in its sole discretion. As a result, our secondary market rate is not a market-determined measure of our
creditworthiness, but rather reflects the market&rsquo;s perception of our parent company&rsquo;s creditworthiness as adjusted for discretionary
factors such as CGMI&rsquo;s preferences with respect to purchasing the securities prior to maturity.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The estimated value of the securities is not an indication of the price, if any, at which CGMI or any other person may be willing
to buy the securities from you in the secondary market.</B> Any such secondary market price will fluctuate over the term of the securities
based on the market and other factors described in the next risk factor. Moreover, unlike the estimated value included in this pricing
supplement, any value of the securities determined for purposes of a secondary market transaction will be based on our secondary market
rate, which will likely result in a lower value for the securities than if our internal funding rate were used. In addition, any secondary
market price for the securities will be reduced by a bid-ask spread, which may vary depending on the aggregate stated principal amount
of the securities to be purchased in the secondary market transaction, and the expected cost of unwinding related hedging transactions.
As a result, it is likely that any secondary market price for the securities will be less than the issue price.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The value of the securities prior to maturity will fluctuate based on many unpredictable factors.</B> The value of your securities
prior to maturity will fluctuate based on the closing values of the underlyings, the volatility of, and correlation between, the closing
values of the underlyings, dividend yields on the underlyings, interest rates generally, the time remaining to maturity and our and Citigroup
Inc.&rsquo;s creditworthiness, as reflected in our secondary market rate, among other factors described under &ldquo;Risk Factors Relating
to the Securities&mdash;Risk Factors Relating to All Securities&mdash;The value of your securities prior to maturity will fluctuate based
on many unpredictable factors&rdquo; in the accompanying product supplement. Changes in the closing values of the underlyings may not
result in a comparable change in the value of your securities. You should understand that the value of your securities at any time prior
to maturity may be significantly less than the issue price.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>Immediately following issuance, any secondary market bid price provided by CGMI, and the value that will be indicated on any brokerage
account statements prepared by CGMI or its affiliates, will reflect a temporary upward adjustment.</B> The amount of this temporary upward
adjustment will steadily decline to zero over the temporary adjustment period. See &ldquo;Valuation of the Securities&rdquo; in this pricing
supplement.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>Our offering of the securities is not a recommendation of any underlying.</B> The fact that we are offering the securities does
not mean that we believe that investing in an instrument linked to the underlyings is likely to achieve favorable returns. In fact, as
we are part of a global financial institution, our affiliates may have positions (including short positions) in the underlyings or in
instruments related to the underlyings, and may publish research or express opinions, that in each case are inconsistent with an investment
linked to the underlyings. These and other activities of our affiliates may affect the closing values of the underlyings in a way that
negatively affects the value of and your return on the securities.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The closing value of an underlying may be adversely affected by our or our affiliates&rsquo; hedging and other trading activities.</B>
We have hedged our obligations under the securities through CGMI or other of our affiliates, who have taken positions in the underlyings
or in financial instruments related to the underlyings and may adjust such positions during the term of the securities. Our affiliates
also take positions in the underlyings or in financial instruments related to the underlyings on a regular basis (taking long or short
positions or both), for their accounts, for other accounts under their management or to facilitate transactions on behalf of customers.
These activities could affect the closing values of the underlyings in a way that negatively affects the value of and your return on the
securities. They could also result in substantial returns for us or our affiliates while the value of the securities declines.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>We and our affiliates may have economic interests that are adverse to yours as a result of our affiliates&rsquo; business activities.</B>
Our affiliates engage in business activities with a wide range of companies. These activities include extending loans, making and facilitating
investments, underwriting securities offerings and providing advisory services. These activities could involve or affect the underlyings
in a way that negatively affects the value of and your return on the securities. They could also result in substantial returns for us
or our affiliates while the value of the securities declines. In addition, in the course of this business, we or our affiliates may acquire
non-public information, which will not be disclosed to you.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The calculation agent, which is an affiliate of ours, will make important determinations with respect to the securities.</B> If
certain events occur during the term of the securities, such as market disruption events and other events with respect to an underlying,
CGMI, as calculation agent, will be required to make discretionary judgments that could significantly affect your return on the securities.
In making these judgments, the calculation agent&rsquo;s interests as an affiliate of ours could be adverse to your interests as a holder
of the securities. See &ldquo;Risk Factors Relating to the Securities&mdash;Risk Factors Relating to All Securities&mdash;The calculation
agent, which is an affiliate of ours, will make important determinations with respect to the securities&rdquo; in the accompanying product
supplement.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="border-bottom: #59AE40 1pt solid; width: 100%; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="padding: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>Even if an underlying pays a dividend that it identifies as special or extraordinary, no adjustment will be required under the
securities for that dividend unless it meets the criteria specified in the accompanying product supplement.</B> In general, an adjustment
will not be made under the terms of the securities for any cash dividend paid by an underlying unless the amount of the dividend per share,
together with any other dividends paid in the same quarter, exceeds the dividend paid per share in the most recent quarter by an amount
equal to at least 10% of the closing value of that underlying on the date of declaration of the dividend. Any dividend will reduce the
closing value of the underlying by the amount of the dividend per share. If an underlying pays any dividend for which an adjustment is
not made under the terms of the securities, holders of the securities will be adversely affected. See &ldquo;Description of the Securities&mdash;Certain
Additional Terms for Securities Linked to an Underlying Company or an Underlying ETF&mdash;Dilution and Reorganization Adjustments&mdash;Certain
Extraordinary Cash Dividends&rdquo; in the accompanying product supplement.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The securities will not be adjusted for all events that may have a dilutive effect on or otherwise adversely affect the closing
value of an underlying.</B> For example, we will not make any adjustment for ordinary dividends or extraordinary dividends that do not
meet the criteria described above, partial tender offers or additional underlying share issuances. Moreover, the adjustments we do make
may not fully offset the dilutive or adverse effect of the particular event. Investors in the securities may be adversely affected by
such an event in a circumstance in which a direct holder of the underlying shares of an underlying would not.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The securities may become linked to an underlying other than an original underlying upon the occurrence of a reorganization event
or upon the delisting of the underlying shares of that original underlying.</B> For example, if an underlying enters into a merger agreement
that provides for holders of its underlying shares to receive shares of another entity and such shares are marketable securities, the
closing value of that underlying following consummation of the merger will be based on the value of such other shares. Additionally, if
the underlying shares of an underlying are delisted, the calculation agent may select a successor underlying. See &ldquo;Description of
the Securities&mdash;Certain Additional Terms for Securities Linked to an Underlying Company or an Underlying ETF&rdquo; in the accompanying
product supplement.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The securities are subject to risks associated with non-U.S. companies.</B> An underlying is a non-U.S. company. The value of an
underlying, therefore, may be affected by political, economic, financial and social factors in the country where an underlying is located,
including changes in that country&rsquo;s governmental, economic and fiscal policies, currency exchange laws or other laws or restrictions.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The securities are linked to ADSs and therefore are subject to currency exchange rate risk.</B> There are significant risks associated
with an investment linked to ADSs that are quoted and traded in U.S. dollars and represent an equity security issued by a foreign company.
If the equity security represented by the ADSs is traded in a foreign currency on a foreign exchange, the price of the ADSs will be affected
by fluctuations in the currency exchange rate between the U.S. dollar and the relevant foreign currency. In addition, if a significant
portion of the underlying&rsquo;s revenues or assets is denominated in one or more foreign currencies, changes in the exchange rate between
the U.S. dollar and those foreign currencies may affect the underlying&rsquo;s financial performance and, in turn, the price of the ADSs.
In recent years, the rate of exchange between the U.S. dollar and some other currencies has been highly volatile and this volatility may
continue in the future. These risks generally depend on economic and political events that cannot be predicted.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>There are important differences between the rights of holders of ADSs and the rights of holders of the equity securities represented
by the ADSs.</B> Because the securities are linked to the performance of ADSs representing an equity security issued by a foreign company
(the &ldquo;underlying equity&rdquo;), you should be aware that important differences exist between the rights of holders of ADSs and
an underlying equity. The ADSs are issued by a financial institution (the &ldquo;ADS depositary&rdquo;) under a deposit agreement, which
sets forth the rights and responsibilities of the ADS depositary, an underlying and holders of the ADSs. The rights of holders of ADSs
under that deposit agreement may be different from the rights of holders of the underlying equity. For example, the underlying may make
distributions in respect of its underlying equity that are not passed on to the holders of its ADSs. Any such differences between the
rights of holders of the ADSs and holders of the underlying equity may be significant and may materially and adversely affect the value
of the securities.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>If the underlying shares of an underlying are delisted, we may call the securities prior to maturity for an amount that may be
less than the stated principal amount.</B> If we exercise this call right, you will receive the amount described under &ldquo;Description
of the Securities&mdash;Certain Additional Terms for Securities Linked to an Underlying Company or an Underlying ETF&mdash;Delisting of
an Underlying Company&rdquo; in the accompanying product supplement. This amount may be less, and possibly significantly less, than the
stated principal amount of the securities.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The U.S. federal tax consequences of an investment in the securities are unclear.</B> There is no direct legal authority regarding
the proper U.S. federal tax treatment of the securities, and we do not plan to request a ruling from the Internal Revenue Service (the
&ldquo;IRS&rdquo;). Consequently, significant aspects of the tax treatment of the securities are uncertain, and the IRS or a court might
not agree with the treatment of the securities as described in &ldquo;United States Federal Tax Considerations&rdquo; below. If the IRS
were successful in asserting an alternative treatment of the securities, the tax consequences of the ownership and disposition of the
securities might be materially and adversely affected. Moreover, future legislation, Treasury regulations or IRS guidance could adversely
affect the U.S. federal tax treatment of the securities, possibly retroactively.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">Non-U.S. investors should note that persons having withholding
responsibility in respect of the securities may withhold on any coupon payment paid to a non-U.S. investor, generally at a rate of 30%.
To the extent that we have withholding responsibility in respect of the securities, we intend to so withhold.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">You should read carefully the discussion under &ldquo;United
States Federal Tax Considerations&rdquo; and &ldquo;Risk Factors Relating to the Securities&rdquo; in the accompanying product supplement
and &ldquo;United States Federal Tax Considerations&rdquo; in this pricing supplement. You should also consult your tax adviser regarding
the U.S. federal tax consequences of an investment in the securities, as well as tax consequences arising under the laws of any state,
local or non-U.S. taxing jurisdiction.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="border-bottom: #59AE40 1pt solid; width: 100%; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="padding: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">Information About Novo Nordisk A/S</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="background-color: white">Novo Nordisk A/S is a healthcare
company engaged in the research, development, manufacturing and marketing of pharmaceutical products in various areas including diabetes
treatment</FONT>. The underlying shares of Novo Nordisk A/S are registered under the Securities Exchange Act of 1934, as amended (the
&ldquo;Exchange Act&rdquo;). Information provided to or filed with the SEC by Novo Nordisk A/S pursuant to the Exchange Act can be located
by reference to the SEC file number 333-82318 through the SEC&rsquo;s website at http://www.sec.gov. In addition, information regarding
Novo Nordisk A/S may be obtained from other sources including, but not limited to, press releases, newspaper articles and other publicly
disseminated documents. The underlying shares of Novo Nordisk A/S trade on the New York Stock Exchange under the ticker symbol &ldquo;NVO.&rdquo;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">We have derived all information regarding Novo Nordisk A/S from publicly
available information and have not independently verified any information regarding Novo Nordisk A/S. This pricing supplement relates
only to the securities and not to Novo Nordisk A/S. We make no representation as to the performance of Novo Nordisk A/S over the term
of the securities.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The securities represent obligations of Citigroup Global Markets Holdings
Inc. (guaranteed by Citigroup Inc.) only. Novo Nordisk A/S is not involved in any way in this offering and has no obligation relating
to the securities or to holders of the securities.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">Historical Information</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The closing value of Novo Nordisk A/S on September 30, 2025 was $55.49.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The graph below shows the closing value of Novo Nordisk A/S for each
day such value was available from January 2, 2015 to September 30, 2025. We obtained the closing values from Bloomberg L.P., without independent
verification. If certain corporate transactions occurred during the historical period shown below, including, but not limited to, spin-offs
or mergers, then the closing values shown below for the period prior to the occurrence of any such transaction have been adjusted by Bloomberg
L.P. as if any such transaction had occurred prior to the first day in the period shown below. You should not take historical closing
values as an indication of future performance.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #EAF3E0">
    <TD STYLE="width: 100%; border: #59AE43 1pt solid; text-align: center"><FONT STYLE="color: #59AE43"><B>Novo Nordisk A/S &ndash; Historical Closing Values</B></FONT><B><FONT STYLE="color: white"><BR>
</FONT><FONT STYLE="color: #59AE43">January 2, 2015 to September 30, 2025</FONT></B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; border-left: #59AE43 1pt solid; text-align: center"><IMG SRC="image_001.jpg" ALT="" STYLE="height: 315px; width: 577px"></TD></TR>
  </TABLE>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="border-bottom: #59AE40 1pt solid; width: 100%; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="padding: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">Information About Oracle Corporation</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Oracle Corporation supplies software for enterprise information management.
The company offers databases and relational servers, application development and decision support tools, and enterprise business applications.
The underlying shares of Oracle Corporation are registered under the Securities Exchange Act of 1934, as amended (the &ldquo;Exchange
Act&rdquo;). Information provided to or filed with the SEC by Oracle Corporation pursuant to the Exchange Act can be located by reference
to the SEC file number 001-35992 through the SEC&rsquo;s website at http://www.sec.gov. In addition, information regarding Oracle Corporation
may be obtained from other sources including, but not limited to, press releases, newspaper articles and other publicly disseminated documents.
The underlying shares of Oracle Corporation trade on the New York Stock Exchange under the ticker symbol &ldquo;ORCL.&rdquo;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">We have derived all information regarding Oracle Corporation from publicly
available information and have not independently verified any information regarding Oracle Corporation. This pricing supplement relates
only to the securities and not to Oracle Corporation. We make no representation as to the performance of Oracle Corporation over the term
of the securities.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The securities represent obligations of Citigroup Global Markets Holdings
Inc. (guaranteed by Citigroup Inc.) only. Oracle Corporation is not involved in any way in this offering and has no obligation relating
to the securities or to holders of the securities.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">Historical Information</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The closing value of Oracle Corporation on September 30, 2025 was $281.24.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The graph below shows the closing value of Oracle Corporation for each
day such value was available from January 2, 2015 to September 30, 2025. We obtained the closing values from Bloomberg L.P., without independent
verification. If certain corporate transactions occurred during the historical period shown below, including, but not limited to, spin-offs
or mergers, then the closing values shown below for the period prior to the occurrence of any such transaction have been adjusted by Bloomberg
L.P. as if any such transaction had occurred prior to the first day in the period shown below. You should not take historical closing
values as an indication of future performance.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #EAF3E0">
    <TD STYLE="width: 100%; border: #59AE43 1pt solid; text-align: center"><FONT STYLE="color: #59AE43"><B>Oracle Corporation &ndash; Historical Closing Values</B></FONT><B><FONT STYLE="color: white"><BR>
</FONT><FONT STYLE="color: #59AE43">January 2, 2015 to September 30, 2025</FONT></B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; border-left: #59AE43 1pt solid; text-align: center"><IMG SRC="image_002.jpg" ALT="" STYLE="height: 315px; width: 577px"></TD></TR>
  </TABLE>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="border-bottom: #59AE40 1pt solid; width: 100%; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="padding: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">United States Federal Tax Considerations</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">You should read carefully the discussion under &ldquo;United States
Federal Tax Considerations&rdquo; and &ldquo;Risk Factors Relating to the Securities&rdquo; in the accompanying product supplement and
&ldquo;Summary Risk Factors&rdquo; in this pricing supplement.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Due to the lack of any controlling legal authority, there is substantial
uncertainty regarding the U.S. federal tax consequences of an investment in the securities. In connection with any information reporting
requirements we may have in respect of the securities under applicable law, we intend (in the absence of an administrative determination
or judicial ruling to the contrary) to treat the securities for U.S. federal income tax purposes as prepaid forward contracts with associated
coupon payments that will be treated as gross income to you at the time received or accrued in accordance with your regular method of
tax accounting. In the opinion of our counsel, Davis Polk &amp; Wardwell LLP, which is based on current market conditions, this treatment
of the securities is reasonable under current law; however, our counsel has advised us that it is unable to conclude affirmatively that
this treatment is more likely than not to be upheld, and that alternative treatments are possible.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Assuming this treatment of the securities is respected and subject to
the discussion in &ldquo;United States Federal Tax Considerations&rdquo; in the accompanying product supplement, the following U.S. federal
income tax consequences should result under current law:</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>Any coupon payments on the securities should be taxable as ordinary income to you at the time received or accrued in accordance with
your regular method of accounting for U.S. federal income tax purposes.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>Upon a sale or exchange of a security (including retirement at maturity for cash), you should recognize capital gain or loss equal
to the difference between the amount realized and your tax basis in the security. For this purpose, the amount realized does not include
any coupon paid on retirement and may not include sale proceeds attributable to an accrued coupon, which may be treated as a coupon payment.
Such gain or loss should be long-term capital gain or loss if you held the security for more than one year.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>If, upon retirement of the securities, you receive underlying shares, you should not recognize gain or loss with respect to the underlying
shares received, other than any fractional underlying share for which you receive cash. Your basis in any underlying shares received,
including any fractional underlying share deemed received, should be equal to your tax basis in the securities. Your holding period for
any underlying shares received should start on the day after receipt. With respect to any cash received in lieu of a fractional share,
you should recognize capital loss in an amount equal to the difference between the amount of cash received in lieu of the fractional share
and the portion of your tax basis in the securities that is allocable to the fractional share.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">We do not plan to request a ruling from the IRS regarding the treatment
of the securities. An alternative characterization of the securities could materially and adversely affect the tax consequences of ownership
and disposition of the securities, including the timing and character of income recognized. In addition, the U.S. Treasury Department
and the IRS have requested comments on various issues regarding the U.S. federal income tax treatment of &ldquo;prepaid forward contracts&rdquo;
and similar financial instruments and have indicated that such transactions may be the subject of future regulations or other guidance.
Furthermore, members of Congress have proposed legislative changes to the tax treatment of derivative contracts. Any legislation, Treasury
regulations or other guidance promulgated after consideration of these issues could materially and adversely affect the tax consequences
of an investment in the securities, possibly with retroactive effect. You should consult your tax adviser regarding possible alternative
tax treatments of the securities and potential changes in applicable law.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">This discussion does not address the U.S. federal tax consequences of
the ownership or disposition of the underlying shares that you may receive at maturity. You should consult your tax adviser regarding
the particular U.S. federal tax consequences of the ownership and disposition of the underlying shares.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Withholding Tax on Non-U.S. Holders.</B> Because significant aspects
of the tax treatment of the securities are uncertain, persons having withholding responsibility in respect of the securities may withhold
on any coupon payment paid to Non-U.S. Holders (as defined in the accompanying product supplement), generally at a rate of 30%. To the
extent that we have (or an affiliate of ours has) withholding responsibility in respect of the securities, we intend to so withhold. In
order to claim an exemption from, or a reduction in, the 30% withholding, you may need to comply with certification requirements to establish
that you are not a U.S. person and are eligible for such an exemption or reduction under an applicable tax treaty. You should consult
your tax adviser regarding the tax treatment of the securities, including the possibility of obtaining a refund of any amounts withheld
and the certification requirement described above.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">As discussed under &ldquo;United States Federal Tax Considerations&mdash;Tax
Consequences to Non-U.S. Holders&rdquo; in the accompanying product supplement, Section 871(m) of the Code and Treasury regulations promulgated
thereunder (&ldquo;Section 871(m)&rdquo;) generally impose a 30% withholding tax on dividend equivalents paid or deemed paid to Non-U.S.
Holders with respect to certain financial instruments linked to U.S. equities (&ldquo;U.S. Underlying Equities&rdquo;) or indices that
include U.S. Underlying Equities. Section 871(m) generally applies to instruments that substantially replicate the economic performance
of one or more U.S. Underlying Equities, as determined based on tests set forth in the applicable Treasury regulations. However, the regulations,
as modified by an IRS notice, exempt financial instruments issued prior to January 1, 2027 that do not have a &ldquo;delta&rdquo; of one.
Based on the terms of the securities and representations provided by us, our counsel is of the opinion that the securities should not
be treated as transactions that have a &ldquo;delta&rdquo; of one within the meaning of the regulations with respect to any U.S. Underlying
Equity and, therefore, should not be subject to withholding tax under Section 871(m).</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">A determination that the securities are not subject to Section 871(m)
is not binding on the IRS, and the IRS may disagree with this treatment. Moreover, Section 871(m) is complex and its application may depend
on your particular circumstances, including your other transactions. You should consult your tax adviser regarding the potential application
of Section 871(m) to the securities.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">We will not be required to pay any additional amounts with respect to
amounts withheld.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>You should read the section entitled &ldquo;United States Federal
Tax Considerations&rdquo; in the accompanying product supplement. The preceding discussion, when read in combination with that section,
constitutes the full opinion of Davis Polk &amp; Wardwell LLP regarding the material U.S. federal tax consequences of owning and disposing
of the securities.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="border-bottom: #59AE40 1pt solid; width: 100%; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="padding: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>You should also consult your tax adviser regarding all aspects of
the U.S. federal income and estate tax consequences of an investment in the securities and any tax consequences arising under the laws
of any state, local or non-U.S. taxing jurisdiction.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">Supplemental Plan of Distribution</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">CGMI, an affiliate of Citigroup Global Markets Holdings Inc. and the
underwriter of the sale of the securities, is acting as principal and will receive an underwriting fee of $35.00 for each security sold
in this offering. From this underwriting fee, CGMI will pay selected dealers not affiliated with CGMI a fixed selling concession of $35.00
for each security they sell. For the avoidance of doubt, any fees or selling concessions described in this pricing supplement will not
be rebated if the securities are automatically redeemed prior to maturity.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">See &ldquo;Plan of Distribution; Conflicts of Interest&rdquo; in the
accompanying product supplement and &ldquo;Plan of Distribution&rdquo; in each of the accompanying prospectus supplement and prospectus
for additional information.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">Valuation of the Securities</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">CGMI calculated the estimated value of the securities set forth on the
cover page of this pricing supplement based on proprietary pricing models. CGMI&rsquo;s proprietary pricing models generated an estimated
value for the securities by estimating the value of a hypothetical package of financial instruments that would replicate the payout on
the securities, which consists of a fixed-income bond (the &ldquo;bond component&rdquo;) and one or more derivative instruments underlying
the economic terms of the securities (the &ldquo;derivative component&rdquo;). CGMI calculated the estimated value of the bond component
using a discount rate based on our internal funding rate. CGMI calculated the estimated value of the derivative component based on a proprietary
derivative-pricing model, which generated a theoretical price for the instruments that constitute the derivative component based on various
inputs, including the factors described under &ldquo;Summary Risk Factors&mdash;The value of the securities prior to maturity will fluctuate
based on many unpredictable factors&rdquo; in this pricing supplement, but not including our or Citigroup Inc.&rsquo;s creditworthiness.
These inputs may be market-observable or may be based on assumptions made by CGMI in its discretionary judgment.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">For a period of approximately three months following issuance of the
securities, the price, if any, at which CGMI would be willing to buy the securities from investors, and the value that will be indicated
for the securities on any brokerage account statements prepared by CGMI or its affiliates (which value CGMI may also publish through one
or more financial information vendors), will reflect a temporary upward adjustment from the price or value that would otherwise be determined.
This temporary upward adjustment represents a portion of the hedging profit expected to be realized by CGMI or its affiliates over the
term of the securities. The amount of this temporary upward adjustment will decline to zero on a straight-line basis over the three-month
temporary adjustment period. However, CGMI is not obligated to buy the securities from investors at any time.&nbsp;&nbsp;See &ldquo;Summary
Risk Factors&mdash;The securities will not be listed on any securities exchange and you may not be able to sell them prior to maturity.&rdquo;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">Validity of the Securities</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">In the opinion of Davis Polk &amp; Wardwell LLP, as special products
counsel to Citigroup Global Markets Holdings Inc., when the securities offered by this pricing supplement have been executed and issued
by Citigroup Global Markets Holdings Inc. and authenticated by the trustee pursuant to the indenture, and delivered against payment therefor,
such securities and the related guarantee of Citigroup Inc. will be valid and binding obligations of Citigroup Global Markets Holdings
Inc. and Citigroup Inc., respectively, enforceable in accordance with their respective terms, subject to applicable bankruptcy, insolvency
and similar laws affecting creditors&rsquo; rights generally, concepts of reasonableness and equitable principles of general applicability
(including, without limitation, concepts of good faith, fair dealing and the lack of bad faith), provided that such counsel expresses
no opinion as to the effect of fraudulent conveyance, fraudulent transfer or similar provision of applicable law on the conclusions expressed
above. This opinion is given as of the date of this pricing supplement and is limited to the laws of the State of New York, except that
such counsel expresses no opinion as to the application of state securities or Blue Sky laws to the securities.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">In giving this opinion, Davis Polk &amp; Wardwell LLP has assumed the
legal conclusions expressed in the opinions set forth below of Alexia Breuvart, Secretary and General Counsel of Citigroup Global Markets
Holdings Inc., and Karen Wang, Senior Vice President &ndash; Corporate Securities Issuance Legal of Citigroup Inc.&nbsp;&nbsp;In addition,
this opinion is subject to the assumptions set forth in the letter of Davis Polk &amp; Wardwell LLP dated February 14, 2024, which has
been filed as an exhibit to a Current Report on Form 8-K filed by Citigroup Inc. on February 14, 2024, that the indenture has been duly
authorized, executed and delivered by, and is a valid, binding and enforceable agreement of, the trustee and that none of the terms of
the securities nor the issuance and delivery of the securities and the related guarantee, nor the compliance by Citigroup Global Markets
Holdings Inc. and Citigroup Inc. with the terms of the securities and the related guarantee respectively, will result in a violation of
any provision of any instrument or agreement then binding upon Citigroup Global Markets Holdings Inc. or Citigroup Inc., as applicable,
or any restriction imposed by any court or governmental body having jurisdiction over Citigroup Global Markets Holdings Inc. or Citigroup
Inc., as applicable.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">In the opinion of Alexia Breuvart, Secretary and General Counsel of
Citigroup Global Markets Holdings Inc., (i) the terms of the securities offered by this pricing supplement have been duly established
under the indenture and the Board of Directors (or a duly authorized committee thereof) of Citigroup Global Markets Holdings Inc. has
duly authorized the issuance and sale of such securities and such authorization has not been modified or rescinded; (ii) Citigroup Global
Markets Holdings Inc. is validly existing and in good standing under the laws of the State of New York; (iii) the indenture has been duly
authorized, executed and delivered by Citigroup Global Markets Holdings Inc.; and (iv) the execution and delivery of such indenture and
of the securities offered by this pricing supplement by Citigroup Global Markets Holdings Inc., and the performance by Citigroup Global
Markets Holdings Inc. of its obligations thereunder, are within its corporate powers and do not contravene its certificate of incorporation
or bylaws or other constitutive documents. This opinion is given as of the date of this pricing supplement and is limited to the laws
of the State of New York.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Alexia Breuvart, or other internal attorneys with whom she has consulted,
has examined and is familiar with originals, or copies certified or otherwise identified to her satisfaction, of such corporate records
of Citigroup Global Markets Holdings Inc., certificates or documents as she has</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="border-bottom: #59AE40 1pt solid; width: 100%; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="padding: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">deemed appropriate as a basis for the opinions expressed above. In such
examination, she or such persons has assumed the legal capacity of all natural persons, the genuineness of all signatures (other than
those of officers of Citigroup Global Markets Holdings Inc.), the authenticity of all documents submitted to her or such persons as originals,
the conformity to original documents of all documents submitted to her or such persons as certified or photostatic copies and the authenticity
of the originals of such copies.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">In the opinion of Karen Wang, Senior Vice President &ndash; Corporate
Securities Issuance Legal of Citigroup Inc., (i) the Board of Directors (or a duly authorized committee thereof) of Citigroup Inc. has
duly authorized the guarantee of such securities by Citigroup Inc. and such authorization has not been modified or rescinded; (ii) Citigroup
Inc. is validly existing and in good standing under the laws of the State of Delaware; (iii) the indenture has been duly authorized, executed
and delivered by Citigroup Inc.; and (iv) the execution and delivery of such indenture, and the performance by Citigroup Inc. of its obligations
thereunder, are within its corporate powers and do not contravene its certificate of incorporation or bylaws or other constitutive documents.&nbsp;&nbsp;This
opinion is given as of the date of this pricing supplement and is limited to the General Corporation Law of the State of Delaware.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Karen Wang, or other internal attorneys with whom she has consulted,
has examined and is familiar with originals, or copies certified or otherwise identified to her satisfaction, of such corporate records
of Citigroup Inc., certificates or documents as she has deemed appropriate as a basis for the opinions expressed above. In such examination,
she or such persons has assumed the legal capacity of all natural persons, the genuineness of all signatures (other than those of officers
of Citigroup Inc.), the authenticity of all documents submitted to her or such persons as originals, the conformity to original documents
of all documents submitted to her or such persons as certified or photostatic copies and the authenticity of the originals of such copies.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">Contact</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Clients may contact their local brokerage representative. Third-party
distributors may contact Citi Structured Investment Sales at (212) 723-7005.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&copy; 2025 Citigroup Global Markets Inc. All rights reserved. Citi
and Citi and Arc Design are trademarks and service marks of Citigroup Inc. or its affiliates and are used and registered throughout the
world.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 14; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>2
<FILENAME>dp235444_exfilingfees.htm
<DESCRIPTION>EX-FILING FEES
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- Template (c) 2024 Novaworks, LLC -->
<!-- Field: Set; Name: AliasFileType; Value: Forms View; Template: Fee Exhibit\Fee Exhibit FC.xds -->
<!-- Field: Set; Name: Platform; Value: Novaworks Fee Exhibit Editor; Version: 1.0a -->
<!-- Field: Set; Name: Control; Value: VGVtcGxhdGU6IChkZWZhdWx0KQ0KQmFzZSBGb250OiBUaW1lcyBOZXcgUm9tYW4sIFRpbWVzLCBTZXJpZg0KQ2FwdGlvbiBTaXplOiAxMnB0DQpUYWJsZSBUaXRsZSBTaXplOiAxMXB0DQpUYWJsZSBIZWFkIFNpemU6IDhwdA0KVGFibGUgQm9keSBTaXplOiAxMHB0 -->
<!-- Field: Set; Name: MD5; Value: ef306dff5cd0f9a8e13ce7fb8967ac96 -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:ffd="http://xbrl.sec.gov/ffd/2024">
<head>
  <title>Filing Fees</title>
  <meta http-equiv="Content-Type" content="text/html"/>
  </head>
<body style="font: 10pt Times New Roman, Times, Serif">

<div style="display: none">
  <ix:header>
    <ix:hidden>
      <ix:nonNumeric name="ffd:SubmissnTp" contextRef="c_report" id="ixv-211">424B2</ix:nonNumeric>
      <ix:nonNumeric name="ffd:FeeExhibitTp" contextRef="c_report" id="ixv-212">EX-FILING FEES</ix:nonNumeric>
      <ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="c_report" id="ixv-213">0000831001</ix:nonNumeric>
      <ix:nonNumeric name="ffd:RegnFileNb" contextRef="c_report" id="ixv-214">333-270327</ix:nonNumeric>
      </ix:hidden>
    <ix:references>
      <link:schemaRef xlink:href="https://xbrl.sec.gov/ffd/2024/ffd-2024.xsd" xlink:type="simple"/>
      </ix:references>
    <ix:resources>
      <xbrli:context id="c_offering_1">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0000831001</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:typedMember dimension="ffd:OfferingAxis"><dei:lineNo>1</dei:lineNo></xbrldi:typedMember>
            </xbrli:segment>
          </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2025-10-02</xbrli:startDate>
          <xbrli:endDate>2025-10-02</xbrli:endDate>
          </xbrli:period>
        </xbrli:context>
      <xbrli:context id="c_offering_2">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0000831001</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:typedMember dimension="ffd:OfferingAxis"><dei:lineNo>2</dei:lineNo></xbrldi:typedMember>
            </xbrli:segment>
          </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2025-10-02</xbrli:startDate>
          <xbrli:endDate>2025-10-02</xbrli:endDate>
          </xbrli:period>
        </xbrli:context>
      <xbrli:context id="c_report">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0000831001</xbrli:identifier>
          </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2025-10-02</xbrli:startDate>
          <xbrli:endDate>2025-10-02</xbrli:endDate>
          </xbrli:period>
        </xbrli:context>
      <xbrli:unit id="USD">
        <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unit>
      <xbrli:unit id="pure">
        <xbrli:measure>xbrli:pure</xbrli:measure>
        </xbrli:unit>
      <xbrli:unit id="shares">
        <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unit>
      </ix:resources>
    </ix:header>
  </div>

<p style="margin-top: 0pt; margin-bottom: 12pt; font-size: 12pt; text-align: right; font-weight: bold">Ex-Filing Fees</p>

<p style="margin-top: 0pt; margin-bottom: 6pt; font-size: 12pt; text-align: center; font-weight: bold">CALCULATION OF FILING FEE TABLES</p>

<p style="margin-top: 0pt; margin-bottom: 6pt; font-size: 12pt; text-align: center; font-weight: bold"><ix:nonNumeric name="ffd:FormTp" contextRef="c_report" id="ixv-248">S-3</ix:nonNumeric></p>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 12pt; text-align: center; font-weight: bold">Citigroup Global Markets Holdings Inc.</p>

<p style="margin-top: 0pt; margin-bottom: 12pt; font-size: 12pt; text-align: center; font-weight: bold"><ix:nonNumeric name="dei:EntityRegistrantName" contextRef="c_report" id="ixv-249">Citigroup Inc</ix:nonNumeric>., as Guarantor</p>

<p style="border-top: Gray 3pt double; font-size: 11pt; padding-top: 6pt; text-align: center; font-weight: bold; margin-top: 0pt; margin-bottom: 4pt">Table 1: Newly Registered and Carry Forward Securities</p>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; border-collapse: collapse; width: 100%">
<tr style="font-size: 2pt; vertical-align: bottom; text-align: center; font-weight: bold">
  <td style="width: 12%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 15%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 15%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 6.5%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 8%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 9%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 9%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 8%">&#160;</td></tr>
<tr style="font-size: 8pt; vertical-align: bottom; text-align: center; font-weight: bold">
  <td style="border-bottom: Black 1pt solid">Line Item Type</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Security Type</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Security Class Title</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Notes</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Fee Calculation<br/> Rule</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Amount Registered</td>
  <td>&#160;</td>
  <td colspan="2" style="border-bottom: Black 1pt solid">Proposed Maximum Offering<br/> Price Per Unit</td>
  <td>&#160;</td>
  <td colspan="2" style="border-bottom: Black 1pt solid">Maximum Aggregate Offering Price</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Fee Rate</td>
  <td>&#160;</td>
  <td colspan="2" style="border-bottom: Black 1pt solid">Amount of Registration Fee</td></tr>
<tr style="font-size: 2pt; vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="22" style="padding-top: 2pt; font-style: italic; text-align: center; padding-bottom: 2pt">Newly Registered Securities</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:PrevslyPdFlg" contextRef="c_offering_1" format="ixt:booleanfalse" id="ixv-250">Fees to be Paid</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="c_offering_1" id="ixv-251">Debt</ix:nonNumeric></td>
  <td>&#160;</td>
  <td><ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="c_offering_1" id="ixv-252">Citigroup Global Markets Holdings Inc. Medium-Term Senior Notes, Series N</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: center">(1)</td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonNumeric name="ffd:Rule457rFlg" contextRef="c_offering_1" format="ixt:booleantrue" id="ixv-253">457(r)</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:AmtSctiesRegd" unitRef="shares" decimals="0" format="ixt:numdotdecimal" contextRef="c_offering_1" id="ixv-254">521</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:MaxOfferingPricPerScty" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="ixv-255">1,000</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:MaxAggtOfferingPric" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="ixv-256">521,000</ix:nonFraction></td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonFraction name="ffd:FeeRate" unitRef="pure" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="ixv-257">0.0001381</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:FeeAmt" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="ixv-258">71.95</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:PrevslyPdFlg" contextRef="c_offering_2" format="ixt:booleanfalse" id="ixv-259">Fees to be Paid</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="c_offering_2" id="ixv-260">Other</ix:nonNumeric></td>
  <td>&#160;</td>
  <td><ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="c_offering_2" id="ixv-261">Citigroup Inc. Guarantee of Medium-Term Senior Notes, Series N</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: center">(2)</td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonNumeric name="ffd:FeesOthrRuleFlg" contextRef="c_offering_2" format="ixt:booleantrue" id="ixv-262">Other</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:AmtSctiesRegd" unitRef="shares" decimals="0" format="ixt:numdotdecimal" contextRef="c_offering_2" id="ixv-263">0</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:MaxOfferingPricPerScty" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_2" id="ixv-264">0.00</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:MaxAggtOfferingPric" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_2" id="ixv-265">0.00</ix:nonFraction></td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonFraction name="ffd:FeeRate" unitRef="pure" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_2" id="ixv-266">0.0001381</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:FeeAmt" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_2" id="ixv-267">0.00</ix:nonFraction></td></tr>
<tr style="font-size: 4pt; vertical-align: top; text-align: left">
  <td style="width: 11%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 15%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 15%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 8%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 8%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 8%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 8%">&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="14" style="text-align: right">Total Offering Amounts:</td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:TtlOfferingAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-268">521,000</ix:nonFraction></td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
 <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:TtlFeeAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-269">71.95</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="14" style="text-align: right">Total Fees Previously Paid:</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:TtlPrevslyPdAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-270">0.00</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="14" style="text-align: right">Total Fee Offsets:</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="border-bottom: Black 1pt solid">&#160;</td>
  <td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ffd:TtlOffsetAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-271">0.00</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="14" style="text-align: right">Net Fee Due:</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="border-bottom: Black 3pt double">$</td>
  <td style="border-bottom: Black 3pt double; text-align: right"><ix:nonFraction name="ffd:NetFeeAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-272">71.95</ix:nonFraction></td></tr>
</table>

<p style="font: bold 8pt Arial, Helvetica, Sans-Serif; color: rgb(50,101,255); margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font-weight: bold; margin-top: 6pt; margin-bottom: 6pt">__________________________________________<br/>
Offering Note(s)</p>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 6pt; width: 100%">
<tr style="vertical-align: top; text-align: justify">
  <td style="width: 15pt; text-align: right">(1)</td><td style="width: 5pt"/>
  <td style="text-align: justify"><ix:nonNumeric name="ffd:OfferingNote" escape="1" contextRef="c_offering_1" id="ixv-273">The filing fee paid with this filing pursuant to Rule 457(r) under the Securities Act of 1933, as amended (the "Securities Act"), was originally deferred in accordance with Rule 456(b) under the
Securities Act.</ix:nonNumeric></td></tr>
  </table>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 6pt; width: 100%">
<tr style="vertical-align: top; text-align: justify">
  <td style="width: 15pt; text-align: right">(2)</td><td style="width: 5pt"/>
  <td style="text-align: justify"><ix:nonNumeric name="ffd:OfferingNote" escape="1" contextRef="c_offering_2" id="ixv-274">No separate consideration will be received for the guarantee, and pursuant to Rule 457(n) under the Securities Act, no separate registration fee is payable.</ix:nonNumeric></td></tr>
  </table>

<p style="border-top: Gray 3pt double; padding-top: 6pt; text-align: center; font-weight: bold; margin-top: 0pt; margin-bottom: 4pt">Narrative Disclosure</p>

<p style="margin-top: 6pt; margin-bottom: 6pt">
The maximum aggregate offering price of the securities to which the prospectus relates is $<ix:nonFraction name="ffd:NrrtvMaxAggtOfferingPric" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" contextRef="c_report" id="ixv-275">521,000</ix:nonFraction>. <ix:nonNumeric name="ffd:FnlPrspctsFlg" contextRef="c_report" format="ixt:booleantrue" id="ixv-276">The
prospectus is a final prospectus for the related offering.</ix:nonNumeric></p>

<p style="margin-top: 6pt; margin-bottom: 6pt">&#160;</p>


</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $[ D$# 2(  A$! Q$!_\0
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M_P#Q5'VB^_Y[0?\ ?D__ !5)10 OVB^_Y[0?]^3_ /%4?:+[_GM!_P!^3_\
M%4E% "_:+[_GM!_WY/\ \51]HOO^>T'_ 'Y/_P 5244 +]HOO^>T'_?D_P#Q
M5'VB^_Y[0?\ ?D__ !5)10 OVB^_Y[0?]^3_ /%4?:+[_GM!_P!^3_\ %4E%
M "_:+[_GM!_WY/\ \51]HOO^>T'_ 'Y/_P 5244 +]HOO^>T'_?D_P#Q5'VB
M^_Y[0?\ ?D__ !5)10 OVB^_Y[0?]^3_ /%4?:+[_GM!_P!^3_\ %4E% "_:
M+[_GM!_WY/\ \51]HOO^>T'_ 'Y/_P 5244 +]HOO^>T'_?D_P#Q5'VB^_Y[
M0?\ ?D__ !5)10 OVB^_Y[0?]^3_ /%4?:+[_GM!_P!^3_\ %4E% "_:+[_G
MM!_WY/\ \51]HOO^>T'_ 'Y/_P 5244 +]HOO^>T'_?D_P#Q5'VB^_Y[0?\
M?D__ !5)10 OVB^_Y[0?]^3_ /%4?:+[_GM!_P!^3_\ %4E% "_:+[_GM!_W
MY/\ \51]HOO^>T'_ 'Y/_P 5244 +]HOO^>T'_?D_P#Q5'VB^_Y[0?\ ?D__
M !5)10 OVB^_Y[0?]^3_ /%4?:+[_GM!_P!^3_\ %4E% "_:+[_GM!_WY/\
M\51]HOO^>T'_ 'Y/_P 5244 +]HOO^>T'_?D_P#Q5'VB^_Y[0?\ ?D__ !5)
M10 OVB^_Y[0?]^3_ /%4?:+[_GM!_P!^3_\ %4E% "_:+[_GM!_WY/\ \51]
MHOO^>T'_ 'Y/_P 5244 +]HOO^>T'_?D_P#Q5'VB^_Y[0?\ ?D__ !5)10 O
MVB^_Y[0?]^3_ /%4?:+[_GM!_P!^3_\ %4E% "_:+[_GM!_WY/\ \51]HOO^
M>T'_ 'Y/_P 5244 +]HOO^>T'_?D_P#Q5'VB^_Y[0?\ ?D__ !5)10 OVB^_
MY[0?]^3_ /%4?:+[_GM!_P!^3_\ %4E% "_:+[_GM!_WY/\ \51]HOO^>T'_
M 'Y/_P 5244 +]HOO^>T'_?D_P#Q5'VB^_Y[0?\ ?D__ !5)10 OVB^_Y[0?
M]^3_ /%4?:+[_GM!_P!^3_\ %4E% "_:+[_GM!_WY/\ \51]HOO^>T'_ 'Y/
M_P 5244 +]HOO^>T'_?D_P#Q5'VB^_Y[0?\ ?D__ !5)10 OVB^_Y[0?]^3_
M /%4?:+[_GM!_P!^3_\ %4E% "_:+[_GM!_WY/\ \53[:ZN3>I#,\3(Z,WRQ
ME2""/<^M1T0?\A2#_KE)_-* -6BBB@ HHHH **CF1Y(61)#&Q& X )'YUSJW
M%[C33)))_P >\!5<L'E<GY_;@8)R#WZ=: .FKGM(_P"0/9_]<EJ;299WN'_>
M22-Y(,ZNQPLV3P,]._ [ 53TEI_['L\0Q_ZI?^6G_P!:@#2HJ+?<?\\8_P#O
MY_\ 6HWW'_/&/_OY_P#6H EHJ+?<?\\8_P#OY_\ 6HWW'_/&/_OY_P#6H EH
MJ+?<?\\8_P#OY_\ 6HWW'_/&/_OY_P#6H EHJ+?<?\\8_P#OY_\ 6HWW'_/&
M/_OY_P#6H EHJ+?<?\\8_P#OY_\ 6HWW'_/&/_OY_P#6H EHJ+?<?\\8_P#O
MY_\ 6HWW'_/&/_OY_P#6H EHJ+?<?\\8_P#OY_\ 6HWW'_/&/_OY_P#6H EH
MJ+?<?\\8_P#OY_\ 6HWW'_/&/_OY_P#6H EHJ+?<?\\8_P#OY_\ 6HWW'_/&
M/_OY_P#6H EHJ+?<?\\8_P#OY_\ 6HWW'_/&/_OY_P#6H EHJ+?<?\\8_P#O
MY_\ 6HWW'_/&/_OY_P#6H EHJ+?<?\\8_P#OY_\ 6HWW'_/&/_OY_P#6H EH
MJ+?<?\\8_P#OY_\ 6HWW'_/&/_OY_P#6H EHJ+?<?\\8_P#OY_\ 6HWW'_/&
M/_OY_P#6H EHJ+?<?\\8_P#OY_\ 6HWW'_/&/_OY_P#6H EHJ+?<?\\8_P#O
MY_\ 6HWW'_/&/_OY_P#6H EHJ+?<?\\8_P#OY_\ 6HWW'_/&/_OY_P#6H EH
MJ+?<?\\8_P#OY_\ 6HWW'_/&/_OY_P#6H EHJ+?<?\\8_P#OY_\ 6HWW'_/&
M/_OY_P#6H EHJ+?<?\\8_P#OY_\ 6HWW'_/&/_OY_P#6H EHJ+?<?\\8_P#O
MY_\ 6HWW'_/&/_OY_P#6H EHJ+?<?\\8_P#OY_\ 6HWW'_/&/_OY_P#6H EH
MJ+?<?\\8_P#OY_\ 6HWW'_/&/_OY_P#6H EHJ+?<?\\8_P#OY_\ 6HWW'_/&
M/_OY_P#6H EHJ+?<?\\8_P#OY_\ 6HWW'_/&/_OY_P#6H EHJ+?<?\\8_P#O
MY_\ 6HWW'_/&/_OY_P#6H EHJ+?<?\\8_P#OY_\ 6HWW'_/&/_OY_P#6H EH
MJ+?<?\\8_P#OY_\ 6HWW'_/&/_OY_P#6H EHJ+?<?\\8_P#OY_\ 6HWW'_/&
M/_OY_P#6H EHJ+?<?\\8_P#OY_\ 6HWW'_/&/_OY_P#6H EHJ+?<?\\8_P#O
MY_\ 6HWW'_/&/_OY_P#6H EHJ+?<?\\8_P#OY_\ 6HWW'_/&/_OY_P#6H EH
M@_Y"D'_7*3^:5%ON/^>,?_?S_P"M3K0R'58?,15_=28PV>Z^PH V**** "BB
MB@ HHHH *Y[2/^0/9_\ 7):Z&N>TC_D#V?\ UR6@"Y1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 444R2:*(J))40L<*&8#<?0>M #Z*** "BBB@ HHHH *(/^0I!
M_P!<I/YI11!_R%(/^N4G\TH U:*** "BBB@ IN]< [A@]#GK230I/"T4@)1A
M@@$C/Y5SYTO4C;:6GEVYCM?L_P"[9B#&5(WGC@G X_'UH Z%)(Y"P1U8J<,
M<X/H:P-(_P"0/9_]<EJQI=C/!,2T7DE(!"SG;^]?.=_!Y_'UJCI,<_\ 8]GB
MX'^J7_EF* -*BHO+G_Y^!_WZ%'ES_P#/P/\ OT* ):*B\N?_ )^!_P!^A1Y<
M_P#S\#_OT* ):*B\N?\ Y^!_WZ%'ES_\_ _[]"@"6BHO+G_Y^!_WZ%'ES_\
M/P/^_0H EHJ+RY_^?@?]^A1Y<_\ S\#_ +]"@"6BHO+G_P"?@?\ ?H4>7/\
M\_ _[]"@"6BHO+G_ .?@?]^A1Y<__/P/^_0H EHJ+RY_^?@?]^A1Y<__ #\#
M_OT* ):*B\N?_GX'_?H4>7/_ ,_ _P"_0H EHJ+RY_\ GX'_ 'Z%'ES_ //P
M/^_0H EHJ+RY_P#GX'_?H4>7/_S\#_OT* ):*B\N?_GX'_?H4>7/_P _ _[]
M"@"6BHO+G_Y^!_WZ%'ES_P#/P/\ OT* ):*B\N?_ )^!_P!^A1Y<_P#S\#_O
MT* ):*B\N?\ Y^!_WZ%'ES_\_ _[]"@"6BHO+G_Y^!_WZ%'ES_\ /P/^_0H
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M+-7^T:C':QH!]BEW"0-R6X_+%=MLFQG[2,>OEBN!OM.?4-3UJ6%O->W</\I
M#+_$?P [5Q8QRY%&/7_ASDQ;ER)1Z_\ #G?6EU'>V<5U%]R50PSVJ:N$MM<E
MTCP[8QV[J9I69]KQY 7<03G/7(KKK.Y^WVJW%M>;XFR ?)QR.O6MJ5:,].MD
M:TJJGIUL7:*B\N?_ )^!_P!^A1Y<_P#S\#_OT*W-B6BHO+G_ .?@?]^A1Y<_
M_/P/^_0H EH@_P"0I!_URD_FE1>7/_S\#_OT*=:+(NJP[Y=_[J3'R 8Y6@#8
MHHHH **** "BBB@ KGM(_P"0/9_]<EKH:Y[2/^0/9_\ 7): +E%%% !1110
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M>0_,_P"-'V2W_P">0_,_XT 3X/H:,'T-0?9+?_GD/S/^-'V2W_YY#\S_ (T
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MJW_Y[Q_]]"IJ* (?M5O_ ,]X_P#OH4?:K?\ Y[Q_]]"IJ* (?M5O_P ]X_\
MOH4?:K?_ )[Q_P#?0J:B@"'[5;_\]X_^^A1]JM_^>\?_ 'T*FHH A^U6_P#S
MWC_[Z%'VJW_Y[Q_]]"IJ* (?M5O_ ,]X_P#OH4?:K?\ Y[Q_]]"IJ* (?M5O
M_P ]X_\ OH4?:K?_ )[Q_P#?0J:B@"'[5;_\]X_^^A1]JM_^>\?_ 'T*FHH
MA^U6_P#SWC_[Z%'VJW_Y[Q_]]"IJ* (?M5O_ ,]X_P#OH4?:K?\ Y[Q_]]"I
MJ* (?M5O_P ]X_\ OH4?:K?_ )[Q_P#?0J:B@"'[5;_\]X_^^A1]JM_^>\?_
M 'T*FHH A^U6_P#SWC_[Z%'VJW_Y[Q_]]"IJ* (?M5O_ ,]X_P#OH4?:K?\
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MJ6B@"+SS_P \)_\ O@?XT>>?^>$__? _QJ6B@"+SS_SPG_[X'^-'GG_GA/\
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MMIUOY%K'Y<>=Q&2>?QJQ7HT8.%-1?0[Z4'""BR+SS_SPG_[X'^-'GG_GA/\
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M6;G^Y#_WV?\ "C-S_<A_[[/^%2T4 19N?[D/_?9_PHS<_P!R'_OL_P"%2T4
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M5+10!%FY_N0_]]G_  HS<_W(?^^S_A4M% $6;G^Y#_WV?\*,W/\ <A_[[/\
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MS_<A_P"^S_A1FY_N0_\ ?9_PJ6BJ&19N?[D/_?9_PHS<_P!R'_OL_P"%2T4
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MP1E1OE^7:GH .YY-=CI^D1:7;F"TF=49MQ+*I)/N<58L+&'3K..WA10%4!F
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M2?S2@#5HHHH **** "BBJUQ?0VLB)+O&X@%@A*KDX&3VR: +-<]I'_('L_\
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M;'_G^M?^_P O^-']HV/_ #_6O_?Y?\: +-%5O[1L?^?ZU_[_ "_XT?VC8_\
M/]:_]_E_QH LT56_M&Q_Y_K7_O\ +_C1_:-C_P _UK_W^7_&@"S15;^T;'_G
M^M?^_P O^-']HV/_ #_6O_?Y?\: +-%5O[1L?^?ZU_[_ "_XT?VC8_\ /]:_
M]_E_QH LT56_M&Q_Y_K7_O\ +_C1_:-C_P _UK_W^7_&@"S15;^T;'_G^M?^
M_P O^-']HV/_ #_6O_?Y?\: +-%5O[1L?^?ZU_[_ "_XT?VC8_\ /]:_]_E_
MQH LT56_M&Q_Y_K7_O\ +_C1_:-C_P _UK_W^7_&@"S15;^T;'_G^M?^_P O
M^-']HV/_ #_6O_?Y?\: +-%5O[1L?^?ZU_[_ "_XT?VC8_\ /]:_]_E_QH L
MT56_M&Q_Y_K7_O\ +_C1_:-C_P _UK_W^7_&@"S15;^T;'_G^M?^_P O^-']
MHV/_ #_6O_?Y?\: +-%5O[1L?^?ZU_[_ "_XT?VC8_\ /]:_]_E_QH LT56_
MM&Q_Y_K7_O\ +_C1_:-C_P _UK_W^7_&@"S15;^T;'_G^M?^_P O^-']HV/_
M #_6O_?Y?\: +-%5O[1L?^?ZU_[_ "_XT?VC8_\ /]:_]_E_QH LT56_M&Q_
MY_K7_O\ +_C1_:-C_P _UK_W^7_&@"S15;^T;'_G^M?^_P O^-']HV/_ #_6
MO_?Y?\: +-%5O[1L?^?ZU_[_ "_XT?VC8_\ /]:_]_E_QH LT56_M&Q_Y_K7
M_O\ +_C1_:-C_P _UK_W^7_&@"S15;^T;'_G^M?^_P O^-']HV/_ #_6O_?Y
M?\: +-%5O[1L?^?ZU_[_ "_XT?VC8_\ /]:_]_E_QH LT56_M&Q_Y_K7_O\
M+_C1_:-C_P _UK_W^7_&@"S15;^T;'_G^M?^_P O^-']HV/_ #_6O_?Y?\:
M+-%5O[1L?^?ZU_[_ "_XT?VC8_\ /]:_]_E_QH LT0?\A2#_ *Y2?S2JW]HV
M/_/]:_\ ?Y?\:DLKJWGU6$0W$4I$4A(1PV.4]* -JBBB@ HHHH **** .>U.
MWN]*C6XTQED8!T\J>55 &QMBJ3C@-CC/3OQ5K2$;S)HS*D]NBIL+&,L&.=P^
M0 !>@'?(/;%6-7BTZ2P:34XDDMX6$GS)NVL#P0!SGMQUSCO46BR12)<>7I_V
M,B0@#[.T6],G:>0,G'Y4 8\DNI&>=99;>.2!7^SNLD.)&,C85P>0 NS(&#P>
M2<5K:T]Y:VD4UDENTBLV])&50_R-@ G_ &]IZC@&J5XVAV>J2Q_9M/2YDD26
MX-QM7*L""ZYZGY>U:>LI826&-1MS/;A@V!$7VD<AN!D8QUH JZ,LGF2(TL<T
M C0C)C+*YR6 V<!1P.>^>U4KJ2]_M*6">2*.W1I)8I(I(0_1-B8<<9S)GCTY
MJ]H-Y9W9N_LMM#!LDP/+BV;D_A)X'/7BJ>JW.B6VJ7 -G!)J3+&TADMV*LN<
M9+!2"0N??H* -&X%T-%B</;I<XC,KK@*>1OVEN.><9]JS_#\EY/.#<A%!C9I
MHF>%OWF1@Q^7G"]<[B3R/>M>>*QOM'*75NOV*2$,T4R;=JXSR.Q'Z8JEHL]I
M-=3?9=.\B'8IAF^RM'YB$#.25'?MWZT 5-:>]BOU1&4VK,F5A>%9(P Q+?O.
M^[;Z\ ]#S5]%O&\/,_FVPO3&Q64X*#DX).,9QC)Z9]JAUO\ LJVN%N+FVM&O
MY()$@>X ".5Y"LQX'/3\<=ZT,V4FE';%%-9-&08XDWJR]P% Y^E &)I,M[/J
M?[S"H9'\Q7D@8.@!"%0F6W8VYSQP?;$WB!KR%U%MY1@=55HE:)7Y;YF_><?=
MZ>^<@\8;I%WI/]J+9V%G'&L<($;^05?<,AE)(SP .2><FK.M2:-#=V<FI0))
M<$LD#- SX^4D@X!P.._?% #[);N71IV:2)K@A_(=BC%1CY=Y4;2<]<<5%9"9
M)H5?4=/N2P DS&HD/'8J<'G/\(JWHTT-UI4;);+ ",/&L91-V/FVY R,Y&<<
MUGV0TJWU**UT_2U$,9D4SI:-B.0,/E#;<8^^.N!@"@"SJ,,_VY=M]:VUJ82/
M+FC5@[Y[@X.,>A%7+'=+;[IFM96W$;K=?EQ^)/-5]8324:UNM4AA;9)Y<4LB
M A"P/4]@<=^,X]JET>2&738GA6U0D?O$M6#(KXY (ZT 9MFMW$D'GZIIL]P0
M%E$D:[@>X5E(_#(JYJ<4_P!HMC#>06D #^;YB*=YXVC![=<X(K+^TZ'9ZE%!
M;Z=&CRW!:;S+5E9"02"N5[MC\R:U-=;2H[:"75H1)&DR>7^Z,A5R< \ ^O/M
MF@";3@7B99)+*8(0%-LF !CN,G%85_)J"W<FV>(,IDV;'@ 4Y^3[W.W'W^Y.
M,<5KZ)<VUQ#,+>U2#;(03'"41AD[2"0,G;@GT)Q5+4%TJTU"00Z6ES=RR))=
M!;5I,*<C<<*1NP#]<4 7]3$\=C$T;1HVX>:4*J2,'[A?C.<=>V:IZ!]K>21;
MEX7C6,;@IC($F3DILZ)Z;N:T=6AL9=*F.H0"6UB7S64KDC;SD#U&*@T>>PF>
MY^QK8KAQM-JRDM'@8+8Z<[N/:@#-U1KU-091*@@5P0L3PJX7;QCS.C[LY)XV
M].:TI!=#08I"UN+O9&99$VA3R-VTGC)&<9XSBL_6I](LKN:=]/CDOW55+2V[
M;9 "/XL8. 3_ "K6O/[.FT.0W42OI[0Y:,QDC9CCY0,T 96BF\?4"LTD3QE7
M:1=T3 G(V%0G.<?>SQGIQ2:Z+UKHP03I;H0AB='B 4[OF\P."<<#&T>M2Z)?
M:;<7I2PLT2-H5:*5;=E;;@9#DJ,'.,#///I4NMIIL,JW4MC'<ZBT3I;KY!D+
MXYP< \9QR>F?>@":+[7_ &"\@>V>\".4D?&T\G:6(XSC&<<9SVK,TL7K:OYG
MVH-;R-\T%P\#. %.2/+'7.W')XW9[5O6J07&FHGV54@D0AH'BVC!Z@J1TZ]J
MR-'FT?[;'!I\-C&B1E(^0)PZDAEQUP .M #/$"WC3-!!,L"-&IB=&A7:^3DR
M"0$E>F-HSP?:M/3UG;2]TKP2S?/LDX((R=N[;QG&,XXSFJ>NOI5O,MS>62RW
M:1,L+O S*<_PE@".HZ=NM:&ES07&E02PQ)'&R\HB;5![@#'KF@#GK(ZE)J44
MINT&[RTEAE>!E8Y^;;M&[;@G;DYSCC&:T?$,YLQ;$3"&!RRR"/8)7.. N\8Q
MUS5.PO-"2]MX--L(_+$KH2+1PZ2;QC;E?N\L<YP !6YJ'V2#RK^Y+JUN=J,@
M+,=Y"[<#).3MX]<4 4]$,C^?',Z/&@0Q(YC:55(_BV?+@XXQVK%2\NI&F9;Q
M6O(-V^3?!]E0;N>V_&!S[]ZV]"BA)N[M;6:VFGD_>(ZNJX4D*5# 8RN"<=R:
MHWJZ,RC0WDBCCCE D22;RVC5E+#RSU(+;5QZ$CM0!;\03M9Q6SK,L$+.1+Y>
MP2OP<!-XQUZ^U+HGF,TT<K*T*I&T*2&-I54YY/E_+M../H:M:F]I;FWO+I9<
MP,2CQ1LVW(P<X!P"/6J?A][.YFOKVVC,<LLFV11NV[5+;" >A(.3CN: ,RXN
M9WU"ZA6Y+74+2&(1- (8UQQOW#=D#[V,UN7LK1:$US'/913")6$TJDQ9X]"#
M@]!]1UZ5E:I>:3$M]I861F9Q)/'Y<GRAR=[1L!][[QX/4^];;VMK)I4<,BLD
M$:(R[CADVX*GV(P#^% %32WWM&9+VPF69698X8-A+#&XYW'.,\\=Z@NYIGUP
MV<=_ID:[5:..2W+R*_H?F YZCO[=Z73Y;;4M<:_2UG39#B"8Q2(LJMM+$@@
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M/LTYD\Q)=W.YB6QNYVY)Q[8H H6T[L]@]G>PW,,UP%G:;RQ*!L8[>  W('0
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M-N=#TZYN%N3;B.X1BRS0DQN&((SE<9X)ZUHT <YX>LI;75;XW$>Z?RXT::-
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M)*74*!ZDCC\N*TI4\V)X]S+N!&Y#@CW!]:BAL;:"Q6R2%3;JNW8_S CWSUH
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M&<<D=36]110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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7 "BBB@ HHHH **** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $[ D$# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HJ
M*YDDAMW>*,.P[,V!]2>:S$UJ25[;;;A(Y45GDD+ *2Q7&0I&>.Y'44 ;%8EG
MJ%_=64-P9+=3(@;:(2<9_P"!5:LM4-S)B2)8T>+SXF#YRF<<\#!Z>O6LG2;J
MW&CV8,\?^J7^(4 :?VB^_P">T'_?D_\ Q5'VB^_Y[0?]^3_\54/VJW_Y[Q_]
M]BC[5;_\]X_^^Q0!-]HOO^>T'_?D_P#Q5'VB^_Y[0?\ ?D__ !50_:K?_GO'
M_P!]BC[5;_\ />/_ +[% $WVB^_Y[0?]^3_\51]HOO\ GM!_WY/_ ,54/VJW
M_P">\?\ WV*/M5O_ ,]X_P#OL4 3?:+[_GM!_P!^3_\ %4?:+[_GM!_WY/\
M\54/VJW_ .>\?_?8H^U6_P#SWC_[[% $WVB^_P">T'_?D_\ Q5'VB^_Y[0?]
M^3_\54/VJW_Y[Q_]]BC[5;_\]X_^^Q0!-]HOO^>T'_?D_P#Q5'VB^_Y[0?\
M?D__ !50_:K?_GO'_P!]BC[5;_\ />/_ +[% $WVB^_Y[0?]^3_\51]HOO\
MGM!_WY/_ ,54/VJW_P">\?\ WV*/M5O_ ,]X_P#OL4 3?:+[_GM!_P!^3_\
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M^Q0!-]HOO^>T'_?D_P#Q5'VB^_Y[0?\ ?D__ !50_:K?_GO'_P!]BC[5;_\
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M;_\ />/_ +[% $WVB^_Y[0?]^3_\51]HOO\ GM!_WY/_ ,54/VJW_P">\?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M?\:,7/\ ?A_[X/\ C4U% $.+G^_#_P!\'_&C%S_?A_[X/^-344 0XN?[\/\
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M4/FS?\^S?]]K_C1YLW_/LW_?:_XT 345#YLW_/LW_?:_XT>;-_S[-_WVO^-
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M0!#]FC]9/^_K?XT?9H_63_OZW^-344 0_9H_63_OZW^-'V:/UD_[^M_C4U%
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MN;K_ %@/.\YS_,=J=7%)T[6U=PJ8E.&V]S>T/5KC14NK.X*^6L'GQ(>?F(!
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MX>:G33N;T)\\$[D7V@?\\I_^_9H^T#_GE/\ ]^S4M%;FQ%]H'_/*?_OV:/M
M_P">4_\ W[-2T4 1?:!_SRG_ ._9H^T#_GE/_P!^S6?K>N1:)'&7B:627.Q
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M:*K%B)/+-^@D_N$+G\J>$E/2ZS]$6BX$U%1>5.>EP?\ OV*/)GSC[0?^_8H
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MU/Y<W_/R?^_8H\N;_GY/_?L5O"A3IN\4;PHP@[Q1-14/ES?\_)_[]BCRYO\
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MR-(^YI&4 _3Z5I45+BFU)[HEQ3:84445104444 %%%% !1110 4444 %%%%
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MM?\ O\O^- %FBJW]HV/_ #_6O_?Y?\:/[1L?^?ZU_P"_R_XT 6:*K?VC8_\
M/]:_]_E_QH_M&Q_Y_K7_ +_+_C0!9HJM_:-C_P _UK_W^7_&C^T;'_G^M?\
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MT 31?:_[!>0/;/>!'*2/C:>3M+$<9QC..,Y[5F:6+UM7\S[4&MY&^:"X>!G
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MT3S&::.5E:%4C:%)#&TJJ<\GR_EVG''T-6M3>TMS;WETLN8&)1XHV;;D8.<
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MBRFF%K);2W$F^:)U<!6VA?E# 87 '3CK0!BV%_>7(\^2XM1- T,+%'C,4@.
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M'1-/MYDECM\&,YC4NQ2,^JJ3M7\!6A0!S'@Q9A:W6^19(]ZA6#(?F"X;[O\
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M.<<#)Z=.]=/%'Y421AF;:,;G.2?J:?0!A:L]U=:C%;Z<'^U6@$S.9 L8#AE
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(4 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>6
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Submission<br></strong></div></th>
<th class="th"><div>Oct. 02, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissionLineItems', window );"><strong>Submission [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Central Index Key</a></td>
<td class="text">0000831001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Registrant Name</a></td>
<td class="text">Citigroup Inc<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_RegnFileNb', window );">Registration File Number</a></td>
<td class="text">333-270327<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FormTp', window );">Form Type</a></td>
<td class="text">S-3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissnTp', window );">Submission Type</a></td>
<td class="text">424B2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeExhibitTp', window );">Fee Exhibit Type</a></td>
<td class="text">EX-FILING FEES<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeExhibitTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeExhibitTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:feeExhibitTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FormTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FormTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_RegnFileNb">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_RegnFileNb</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissnTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissnTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Offerings<br></strong></div></th>
<th class="th">
<div>Oct. 02, 2025 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=1', window );">Offering: 1</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule457rFlg', window );">Rule 457(r)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Debt<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Citigroup Global Markets Holdings Inc. Medium-Term Senior Notes, Series N<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_AmtSctiesRegd', window );">Amount Registered | shares</a></td>
<td class="nump">521<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxOfferingPricPerScty', window );">Proposed Maximum Offering Price per Unit</a></td>
<td class="nump">1,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 521,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01381%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 71.95<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text">The filing fee paid with this filing pursuant to Rule 457(r) under the Securities Act of 1933, as amended (the "Securities Act"), was originally deferred in accordance with Rule 456(b) under the
Securities Act.<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=2', window );">Offering: 2</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesOthrRuleFlg', window );">Other Rule</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Other<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Citigroup Inc. Guarantee of Medium-Term Senior Notes, Series N<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_AmtSctiesRegd', window );">Amount Registered | shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxOfferingPricPerScty', window );">Proposed Maximum Offering Price per Unit</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01381%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text">No separate consideration will be received for the guarantee, and pursuant to Rule 457(n) under the Securities Act, no separate registration fee is payable.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_AmtSctiesRegd">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of securities being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_AmtSctiesRegd</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegativeDecimal2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total amount of registration fee (amount due after offsets).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesOthrRuleFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesOthrRuleFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_MaxAggtOfferingPric">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum aggregate offering price for the offering that is being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_MaxAggtOfferingPric</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative100TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_MaxOfferingPricPerScty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum offering price per share/unit being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_MaxOfferingPricPerScty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegativeDecimal4lItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTitl">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The title of the class of securities being registered (for each class being registered).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTitl</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Type of securities: "Asset-backed Securities", "ADRs/ADSs", "Debt", "Debt Convertible into Equity", "Equity", "Face Amount Certificates", "Limited Partnership Interests", "Mortgage Backed Securities", "Non-Convertible Debt", "Unallocated (Universal) Shelf", "Exchange Traded Vehicle Securities", "Other"</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_PrevslyPdFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_PrevslyPdFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_Rule457rFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 457<br> -Subsection r<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_Rule457rFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fees Summary<br></strong></div></th>
<th class="th">
<div>Oct. 02, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesSummaryLineItems', window );"><strong>Fees Summary [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOfferingAmt', window );">Total Offering</a></td>
<td class="nump">$ 521,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlPrevslyPdAmt', window );">Previously Paid Amount</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlFeeAmt', window );">Total Fee Amount</a></td>
<td class="nump">71.95<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOffsetAmt', window );">Total Offset Amount</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NetFeeAmt', window );">Net Fee</a></td>
<td class="nump">71.95<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NrrtvMaxAggtOfferingPric', window );">Narrative - Max Aggregate Offering Price</a></td>
<td class="nump">$ 521,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FnlPrspctsFlg', window );">Final Prospectus</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesSummaryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesSummaryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FnlPrspctsFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FnlPrspctsFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NetFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NetFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NrrtvMaxAggtOfferingPric">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NrrtvMaxAggtOfferingPric</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative100TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOfferingAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOfferingAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOffsetAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOffsetAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlPrevslyPdAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlPrevslyPdAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>3</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>1</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="dp235444_exfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995210 - Document - Submission</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/submissionTable</Role>
      <ShortName>Submission</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="dp235444_exfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995211 - Document - Offerings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesOfferingTable</Role>
      <ShortName>Offerings</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="dp235444_exfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>995215 - Document - Fees Summary</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesSummaryTable</Role>
      <ShortName>Fees Summary</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="EX-FILING FEES" original="dp235444_exfilingfees.htm">dp235444_exfilingfees.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="2">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
    <BaseTaxonomy items="31">http://xbrl.sec.gov/ffd/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "dp235444_exfilingfees.htm": {
   "dts": {
    "inline": {
     "local": [
      "dp235444_exfilingfees.htm"
     ]
    },
    "schema": {
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/arcrole/deprecated-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/ffd/2024/ffd-2024.xsd"
     ]
    }
   },
   "keyStandard": 24,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 1,
   "memberCustom": 0,
   "hidden": {
    "total": 4,
    "http://xbrl.sec.gov/ffd/2024": 3,
    "http://xbrl.sec.gov/dei/2024": 1
   },
   "contextCount": 3,
   "entityCount": 1,
   "segmentCount": 1,
   "elementCount": 107,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ffd/2024": 31,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/ffd/role/document/submissionTable",
     "longName": "995210 - Document - Submission",
     "shortName": "Submission",
     "isDefault": "true",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c_report",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp235444_exfilingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c_report",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp235444_exfilingfees.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
     "longName": "995211 - Document - Offerings",
     "shortName": "Offerings",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c_offering_1",
      "name": "ffd:PrevslyPdFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp235444_exfilingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c_offering_1",
      "name": "ffd:PrevslyPdFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp235444_exfilingfees.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable",
     "longName": "995215 - Document - Fees Summary",
     "shortName": "Fees Summary",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "3",
     "firstAnchor": {
      "contextRef": "c_report",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp235444_exfilingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c_report",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp235444_exfilingfees.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ffd_AggtRedRpPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "AggtRedRpPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtRedRpPricPrrFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "AggtRedRpPricPrrFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Prior Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, Prior FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtSalesPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "AggtSalesPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Sales Price, Fiscal Year",
        "terseLabel": "Aggregate Sales Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtRedCdts": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "AmtRedCdts",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Redemption Credits",
        "terseLabel": "Redemption Credits"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtSctiesRcvd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "AmtSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Received",
        "terseLabel": "Amount of Securities Received",
        "documentation": "Amount of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_AmtSctiesRegd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "AmtSctiesRegd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Registered",
        "terseLabel": "Amount Registered",
        "documentation": "The amount of securities being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CeasedOprsDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CeasedOprsDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ceased Operations Date",
        "terseLabel": "Ceased Operations Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CfwdFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CfwdFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Form Type",
        "terseLabel": "Carry Forward Form Type",
        "documentation": "The Form Type of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrevslyPdFee": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CfwdPrevslyPdFee",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Previously Paid Fee",
        "terseLabel": "Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward",
        "documentation": "The fee previously paid in connection with the securities being brought forward from the prior shelf registration statement on which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CfwdPrrFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Prior Effective Date",
        "terseLabel": "Carry Forward Initial Effective Date",
        "documentation": "The initial effective date of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CfwdPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward File Number",
        "terseLabel": "Carry Forward File Number",
        "documentation": "The EDGAR File Number of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). If the prior registration statement has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CmbndPrspctsItemAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CmbndPrspctsItemAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Item [Axis]",
        "terseLabel": "Combined Prospectus",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different references to earlier prospectuses on a single fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CmbndPrspctsLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Line Items]",
        "terseLabel": "Combined Prospectus:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CmbndPrspctsTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Table]",
        "terseLabel": "Combined Prospectus Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CombinedProspectusTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CombinedProspectusTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Table [N/A]",
        "terseLabel": "Combined Prospectus Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CshPdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CshPdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Paid by Registrant in Transaction",
        "terseLabel": "Cash Consideration Paid",
        "documentation": "Amount of cash consideration paid by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "ffd_CshRcvdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CshRcvdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Received by Registrant in Transaction",
        "terseLabel": "Cash Consideration Received",
        "documentation": "Amount of cash consideration received by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "ffd_FeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Amount",
        "terseLabel": "Amount of Registration Fee",
        "documentation": "Total amount of registration fee (amount due after offsets)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeExhibitTp": {
     "xbrltype": "feeExhibitTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FeeExhibitTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Exhibit Type",
        "terseLabel": "Fee Exhibit Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_FeeIntrstAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FeeIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Interest Amount",
        "terseLabel": "Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FeeNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note",
        "terseLabel": "Fee Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNoteMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FeeNoteMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note Maximum Aggregate Offering Price",
        "terseLabel": "Fee Note MAOP"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FeeRate",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Rate",
        "terseLabel": "Fee Rate",
        "documentation": "The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesOthrRuleFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FeesOthrRuleFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees, Other Rule [Flag]",
        "terseLabel": "Other Rule",
        "documentation": "Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesSummaryLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FeesSummaryLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees Summary [Line Items]",
        "terseLabel": "Fees Summary:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FnlPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FnlPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Final Prospectus [Flag]",
        "terseLabel": "Final Prospectus"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FormTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Form Type",
        "terseLabel": "Form Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_GnlInstrIIhiFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "GnlInstrIIhiFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Instruction II.H,I [Flag]",
        "terseLabel": "General Instruction II.H,I"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrCity": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "IssrBizAdrCity",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, City",
        "terseLabel": "City"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStatOrCtryCd": {
     "xbrltype": "stateOrCountryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "IssrBizAdrStatOrCtryCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, State or Country Code",
        "terseLabel": "State or Country Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt1": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "IssrBizAdrStrt1",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 1",
        "terseLabel": "Street 1"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt2": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "IssrBizAdrStrt2",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 2",
        "terseLabel": "Street 2"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrZipCd": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "IssrBizAdrZipCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Zip Code",
        "terseLabel": "Zip Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrNm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "IssrNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Name",
        "terseLabel": "Issuer Name"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_MaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "MaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Aggregate Offering Price",
        "terseLabel": "Maximum Aggregate Offering Price",
        "documentation": "The maximum aggregate offering price for the offering that is being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_MaxOfferingPricPerScty": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "MaxOfferingPricPerScty",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Offering Price per Security",
        "terseLabel": "Proposed Maximum Offering Price per Unit",
        "documentation": "The maximum offering price per share/unit being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetFeeAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "NetFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Fee Amount",
        "terseLabel": "Net Fee"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetSalesAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "NetSalesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Sales Amount",
        "terseLabel": "Net Sales"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvDsclsr": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "NrrtvDsclsr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure",
        "terseLabel": "Narrative Disclosure"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "NrrtvMaxAggtAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Amount",
        "terseLabel": "Narrative - Max Aggregate Offering Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "NrrtvMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Price",
        "terseLabel": "Narrative - Max Aggregate Offering Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OfferingAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Axis]",
        "terseLabel": "Offering",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different security offerings on a single fee bearing submission."
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OfferingLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Line Items]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OfferingNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Note",
        "terseLabel": "Offering Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OfferingSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Title",
        "terseLabel": "Security Class Title",
        "documentation": "The title of the class of securities being registered (for each class being registered)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OfferingSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Type",
        "terseLabel": "Security Type",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OfferingTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Table]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OfferingTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Table [N/A]",
        "terseLabel": "Offering Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset [Axis]",
        "terseLabel": "Offset",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different offsets as applied to a fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetClmInitlFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetClmInitlFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claim Initial Filing Date",
        "terseLabel": "Initial Filing Date",
        "documentation": "The initial filing date of the earlier registration statement with which the earlier (offsetting) fee was paid for a claimed offset. If the offset fee was paid with an amendment, do not provide the amendment date under this element; instead, provide the date of the initial filing (i.e. the \"parent\" filing) ."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Amount",
        "terseLabel": "Fee Offset Claimed",
        "documentation": "The amount of offsetting fees being claimed."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdInd": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetClmdInd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Indicator",
        "terseLabel": "Offset Claimed"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetExpltnForClmdAmt": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetExpltnForClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Explanation for Claimed Amount",
        "terseLabel": "Explanation for Claimed Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetLineItems",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset:",
        "label": "Offset [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Note",
        "terseLabel": "Offset Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetPrrFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetPrrFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Fee Amount",
        "terseLabel": "Fee Paid with Fee Offset Source",
        "documentation": "The fee prevoiusly paid from which an offset is being derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior File Number",
        "terseLabel": "File Number",
        "documentation": "The EDGAR File Number of the earlier registration statement with which the earlier (offsetting) fee was paid. If the offset filing for the offset has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFilerNm": {
     "xbrltype": "filerNameItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetPrrFilerNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Filer Name",
        "terseLabel": "Registrant or Filer Name",
        "documentation": "The name of the registrant that filed the earlier registration statement with which the earlier (offsetting) fee was paid."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetPrrFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Form Type",
        "terseLabel": "Form or Filing Type",
        "documentation": "The Form Type of the offset filing."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrNbOfUnsoldScties": {
     "xbrltype": "nonNegativeIntegerItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetPrrNbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Number of Securities",
        "terseLabel": "Unsold Securities Associated with Fee Offset Claimed",
        "documentation": "The number of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetPrrSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Title",
        "terseLabel": "Security Title Associated with Fee Offset Claimed",
        "documentation": "The title of the class of securities from which offset fees were derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetPrrSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Type",
        "terseLabel": "Security Type Associated with Fee Offset Claimed",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrUnsoldOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetPrrUnsoldOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Offering Amount",
        "terseLabel": "Unsold Aggregate Offering Amount Associated with Fee Offset Claimed",
        "documentation": "The aggregate offering amount of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetSrcFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetSrcFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Source Filing Date",
        "terseLabel": "Filing Date",
        "documentation": "The filing date of the earlier registration statement with which the earlier (offsetting) fee was paid in an offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset Payment:",
        "label": "Offset [Table]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Table [N/A]",
        "terseLabel": "Offset Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_PrevslyPdFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "PrevslyPdFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Previously Paid [Flag]",
        "terseLabel": "Fee Previously Paid"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RegnFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "RegnFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration File Number",
        "terseLabel": "Registration File Number"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RptgFsclYrEndDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "RptgFsclYrEndDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reporting Fiscal Year End Date",
        "terseLabel": "Reporting FY End Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule011Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 0-11 [Flag]",
        "terseLabel": "Rule 0-11"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011a2OffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule011a2OffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 0-11(a)(2) Offset",
        "label": "Rule 0-11(a)(2) Offset [Flag]"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule415a6Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule415a6Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 415(a)(6) [Flag]",
        "terseLabel": "Rule 415(a)(6)",
        "documentation": "Checkbox indicating whether filer is claiming a 415(a)(6) carryforward."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_Rule429AggtOfferingAmt": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429AggtOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Aggregate Offering Amount",
        "terseLabel": "Maximum Aggregate Offering Price of Securities Previously Registered",
        "documentation": "The maximum aggregate offering amount of unsold securities registered on the prior registration statement that are carried forward under Rule 429. Only applicable if 457(o) was used in the fee calculation for the prior registration statement."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429CmbndPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429CmbndPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Combined Prospectus [Flag]",
        "terseLabel": "Rule 429",
        "documentation": "Checkbox indicating whether filer is using a combined prospectus under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429EarlierFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier File Number",
        "terseLabel": "File Number",
        "documentation": "The Securities Act File Number of the earlier effective registration statement(s) from which securities may be offered and sold using the combined prospectus pursuant to Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429EarlierFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier Form Type",
        "terseLabel": "Form Type",
        "documentation": "The Form Type of the earlier registration statement from which unsold securities are carried forward under Rule 429. This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429InitlFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429InitlFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Initial Effective Date",
        "terseLabel": "Initial Effective Date",
        "documentation": "The filing date of the earlier registration statement from which unsold securities are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429NbOfUnsoldScties": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429NbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Number Of Unsold Securities",
        "terseLabel": "Amount of Securities Previously Registered",
        "documentation": "The number of securities registered on the prior registration statement that are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429PrspctsNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429PrspctsNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Prospectus Note",
        "terseLabel": "Combined Prospectus Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429SctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Title",
        "terseLabel": "Security Class Title"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429SctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Type",
        "terseLabel": "Security Type"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule457aFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule457aFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(a) [Flag]",
        "terseLabel": "Rule 457(a)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(a) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "ffd_Rule457bOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule457bOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(b) Offset [Flag]",
        "terseLabel": "Rule 457(b) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(b) or 0-11(a)(2)."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "ffd_Rule457fFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule457fFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(f) [Flag]",
        "terseLabel": "Rule 457(f)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_Rule457oFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule457oFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(o) [Flag]",
        "terseLabel": "Rule 457(o)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(o) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "ffd_Rule457pOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule457pOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(p) Offset [Flag]",
        "terseLabel": "Rule 457(p) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(p)."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "ffd_Rule457rFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule457rFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(r) [Flag]",
        "terseLabel": "Rule 457(r)"
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "ffd_Rule457sFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule457sFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(s) Flag",
        "terseLabel": "Rule 457(s)"
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "ffd_Rule457uFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule457uFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(u) [Flag]",
        "terseLabel": "Rule 457(u)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(u) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "ffd_Scties424iAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Scties424iAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Axis]",
        "terseLabel": "Securities, 424I"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Scties424iLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Line Items]",
        "terseLabel": "Securities, 424I:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Scties424iTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Table]",
        "terseLabel": "Securities, 424I Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Securities424iTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Securities424iNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities 424I [N/A]",
        "terseLabel": "Securities 424I N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "SubmissionLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission [Line Items]",
        "terseLabel": "Items"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissnTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "SubmissnTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission Type",
        "terseLabel": "Submission Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TermntnCmpltnWdrwl": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "TermntnCmpltnWdrwl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Termination / Completion / Withdrawal Statement",
        "terseLabel": "Termination / Withdrawal Statement"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TtlFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "TtlFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee Amount",
        "terseLabel": "Total Fee Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlFeeAndIntrstAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "TtlFeeAndIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee and Interest Amount",
        "terseLabel": "Total Fee and Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "TtlOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offering Amount",
        "terseLabel": "Total Offering"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOffsetAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "TtlOffsetAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offset Amount",
        "terseLabel": "Total Offset Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlPrevslyPdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "TtlPrevslyPdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Previously Paid Amount",
        "terseLabel": "Previously Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlTxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "TtlTxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Transaction Valuation",
        "terseLabel": "Total Transaction Valuation"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "TxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transaction Valuation",
        "terseLabel": "Transaction Valuation"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_ValSctiesRcvd": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "ValSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received",
        "terseLabel": "Value of Securities Received",
        "documentation": "Value of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_ValSctiesRcvdPerShr": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "ValSctiesRcvdPerShr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received, Per Share",
        "terseLabel": "Value of Securities Received, Per Share",
        "documentation": "Value per share of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form). This is included in the explanation of 457(f) fee calculation."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "415",
   "Subsection": "a"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "429"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "f"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "o"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "p"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "r"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "s"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "u"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Subsection": "f",
   "Section": "457"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0000950103-25-012738-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000950103-25-012738-xbrl.zip
M4$L#!!0    ( -EM0ENDNB?]3@L  (!!   9    9' R,S4T-#1?97AF:6QI
M;F=F965S+FAT;>T;:W/:.O9[?H76>W>;S@2PS2N0A!U"2BZW*>E-2).;V9F.
ML 5HX]=*XG5__1[9V!ABP*1 NYW;Z;18.CYOG8<DG_]K8EMH1!BGKG/Q3LNJ
M[Q!Q#->D3O_B7?V^T6J]^U?MZ/QOF0SJ$-NSL"#HV'B/=%4OH+8[PF.7O? 3
M='/30)G,#+))B656T3T19ZB-;5)%=8MBWJ06Z4P]<H:^8&L(HTV7V1Q]H61\
M%F&'44+0A\F =JGX=^PW:C:R$Y.OH_(9$/0 9T0@8C".%'TPJ7 9  5B5Q&(
MC=?A;;B.8*X5H?UR_448UY.!>?U0:C4&+\^/SP/S<:)^_!W^VLT_G^\OK[MZ
M4;VEEP_X4;.,Z>7M\Y/1?[ KXH_' F\U[[SNXY<_;QJ7G>>GW[SG/KRG-\?F
MM37JTLL.?O*L6UJ??'(NU:O?O8<_'G_C@/,!/]W)_^?S3POSK>?'YDNKV?:(
M#7Q=#<9F7?WXY;I)N]</_=_MR@N)O_OKI;I.YD]7Q4A>TLNK);/7*QJFVJO@
M4Z+E#5+N=4\KI3(V*J4 ST" *X$[.?Q"&0CA57.Y\7B<'>>S+NOGM$JEDIM(
M&"4 JDXLZKRL!I6S$6B7670!5([XP+JJYG/4X0([!HG#F_,7XL"E7# 9@E+N
M%G2MO YY !&],%D%JTE&@&WR='EW,P<7R?!ST)Q@V.'2<;$ ?Y28BAE5S^BE
M&)(,)\8"(GC.]MW11CRGF;P6XGFE\45)Y707\TB-)EG284@3)G(R H2 O9Z9
M# @3 :#T#X+-VA%"YX(*B]0@&D"0D0N3G^>"(3EI$X&11)4A_QW2T84B%Q]Q
M1$9&#@49P=.%(LA$Y'QWROGOY0+TYUW7G"(NIA:Y4'H #*M;]03J4)MPU"9C
M=.?:V#D)!D[ XQGM 7='YR8=A>^9E$,LFE:1XSI$\='32542($P^S9ZI:1(G
M> Y& +P]M &C@1Q81,! SZS>#[LVY=SI>#/N)^*.]"X4XRLCGLN$@B@HCTY&
M&5W3E%I!+USJY[D%;!MI@!)GP2T-%5VI?7C*-%LWK?8U:G[X<+\-.3!]]8,#
M]IHVP X,6RW'))./9+J9;EZIJ?#G-*^IJK:MB'>D[\@$TNYN)@3NEL_G,WI9
MS>OE581R2R:4E!GI$0;YC_ (3*Z)*C<&Q,9 #_EAJ3I@DK3T4K[*X^6/C/R1
MG7!3F;TGP(<O%$XAU9' ;R-6EDD'['!WR.+<^(&P.I/?E]CXZO;@35A*7S4E
MA(L@B6^I^7 T04TYU:.$(5\XDAA;&JV/BS9;?CD!,R=]&Z;C,[,YD_H*,#\1
MNPMT35B!CE]W^ :^G8E1GU"NU,ZEG\G UG9K0#?V=)Y[C6N)6&XE)^'4LEYF
MO'O @6LF"24P$U=0GM3 I,6,ID)\CLA$<Z_?(XZYXJUP)H&Y92["\9G9TSF#
M_I,Z@_Z7,Z1VAEED_+Z.\/,I>>C00,,/]U>OE6L3S(>,U&9E8Q6 0G3AU"LZ
M$N,J(AZ\L9K*C'_X^4U$^ !#LME$)H#:CE#N=1X+4F]43<&"IB-9@7EA_65C
MUJ=.1KA>%4'Q=H9F UU7"->&BDZ7@[*ZRW#Z)PD'I*DRV*)]:.D8[0]"F#&1
M#U74=2T32I])9J'T]+8B7=I(V0!/)RR1=*-^TWBXJ7=:MVUTVT3S"@QUZI<W
ML@X[(#.KBTEH(%*4D853I7:?R2^75]O*H'Z30JF@?>8./71MN5ULH4^8O1#!
MT:\P#2;FJ.48V6U92N%>V^IU7C5#'4NY;-2$[+,W:[D2EQ*D6=9W]@1ACJZ'
M6*)TV;*L79?!,@MDO69XBO+0#)GNL&N111$U*:*'3:FV +R46NA(@RM56O @
M#74P4$5:5;9AUA0%FH"BUT38,5$#,S:56T)CS$SHRXPA [FC%2K\EPUB63,F
M+Q15\9^YAXWP.=;XA8+Y[,S48+B6A3T.P^&O,S2FIAA(./4?LDL5+ &);_\1
M88(:V K5$<B6VB_\SM<,D8=4=2#ZS[]K)?4,FF S&4C-%E- :6F #HZJE HJ
M':[3G6&J[$Y5*6!V:)B#RG98OI>L"_^P5<OQ=.?+<18?PG!U:6'C!4%(1-RU
M*$#?0+N!6H+82&Y#)0@11LXHA\B MU+D3>1FT6]Z8&H-"W...G(O;N]$VZ[P
M-_[V2T5N^S>P90PM?TOTO,MR-70W/(!\==L=.B*6Y&(X$K!"/H(\!MVOKJ2E
M\)FYGLLA>W["$VH/;10VS8&4GZ$Z(.@SM'(/4(_OG'I(M-[O,]*7QT(A^8#R
M04Q[!W1W+MG,<FX/A;6:=!W9+6P,3(EU A1%BU')(CVAK&3YKY'#C[RRZ58V
MC#G9W,L62NE80R%GJX@*P&,D)ZOE9:++9?*J9(X7R-\N09B*!U20C"RHB3S\
M&#/LK6D4/S,RXM;TL]FT^LN-3&Q3&@4G4K*A$=6NZUH$.SULR6.FJ,TIJOZ"
MYL FZD+4PM1\W5BN6^=O$B",6/>&F+[N>.,BS!G5E-H5Z8JMN$O) >3==#SH
M:3M?](F8=&AG.H39X#$.=1GR$V]P\"5/Q-ZDYM=NJ]2.M?=O?G?UJ0^DZD*Q
MS+;W,,&&"PZ65VJ Z)B]_V:!_:VEB.<FPX:?'^9,UVT!]@3MPG(U%22WPWR>
M9YMLR"0&M6$!^!UKG'5G:)NNF$VG<X6"4BOJT6%:R,P&=_SE6R6$Y!]ZKDSV
M4&1(!XZ)*G=&8W*VVLUOEK2HU+03556_@ZQ0XXBXO/L5M.2;='M14RRP!/$@
MZLHJ*B:2O^&\8YG*2DW-@D1:_O3@S@H2PHK<K\U.E5I9RU:*R;+]L,E93Y><
M*S]P<M9CC):@BK@5 \(.G9T7F-"6=FRSX>XL-"S05!PR)>M[2,G2$T#)3*;F
M[7UK*2V7]+=8[$?,R@LN(&^Z_*0Y>4'.0A#6?\:4O"!G\2UR_F#Y>$&@TL^7
MCQ?D*Z\SV+H=G,+6.SC+6]UI]KI3P>QJ8WUGB/:TT__=\1Q$]O6[CO-CR!W@
MV)5>_H]EWM6&GE90UL2XCBNP-=_W#C:.>77/\;,CK.AZG(RCR3<(TL?3Q3@\
MCZ&G;^Q#-XWL2@EA'MF7_)5]]G1;>9C??,F&CKI#Z.G\#FR#EQUPY*WVBSK4
M?5JQK&Y5">S7B#)4<+(Q0NS=4IM.P-X<C-\0QT ?>[6_]OWMWR;"M_[5D/R0
MEI]?"5,2 _.&E[8T.VACSY&[K*>)W#G_1MG"9;G@>R%Y/T1>,4%U1K%U@GXE
MUHA(KSA!]]CA&?^3H3-I?)>!O/WN<5$]T53M1"\6WV^^"J?&3[V]5_377*PK
M)5\!56I?4__QKP8<116+W'@ZYN]W<L4NU675E9?M-BZ\_PRYH+WIJJZKF'@!
M>'XJE5#=@N9R:U)81'#C]J#4HH((-[#\ND=+M6-<SD->&!#4"ZXB]R \>)#5
M04%B@,2 \G &NG\^Q(Z0FZ]RRPT%IUC@^[ F 9+$3H)1W?#O+6B5?-Z_%@JL
M IB)CB6<L@BHO#]!8X!Q05/4P1;4%:;\!DD>+E,'8<. 92\_J@QXFM$N'7=C
MM(\64683=_&"]09ZGJ^XG]+3]!_'T^)[(>6"O&R%./$PD]=TX!5.P7[!K98Q
MM2RYJ<^(0>@(3 _AUO>J?KAG?>+?SDUT0V>U&YX@)T:3Q2_22%\'__;P5'I!
M:I])=Z5YOS>8VYA)(4:0RRDW+)?[WUVLOEV^,F(?R;5OSZY0X>@*56A Y/F7
MMV I2\WRN69!^^,!-0;^N,=<[A%###DH6'X[SZ5>?UF3>AD3H\3-T[?FW VW
MU\O%U3UD=LWGK XT!]PS!$\X8 B);#Y<*)?\&'L4TQ/H!T-DA7 7UU[H\X$6
MS<@,";[Y!EO'<SV4'?(#95E^R&^7:_\#4$L! A0#%     @ V6U"6Z2Z)_U.
M"P  @$$  !D              ( !     &1P,C,U-#0T7V5X9FEL:6YG9F5E
;<RYH=&U02P4&      $  0!'    A0L

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>dp235444_exfilingfees_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:ffd="http://xbrl.sec.gov/ffd/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef
      xlink:href="https://xbrl.sec.gov/ffd/2024/ffd-2024.xsd"
      xlink:type="simple"/>
    <context id="c_offering_1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000831001</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>1</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-10-02</startDate>
            <endDate>2025-10-02</endDate>
        </period>
    </context>
    <context id="c_offering_2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000831001</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>2</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-10-02</startDate>
            <endDate>2025-10-02</endDate>
        </period>
    </context>
    <context id="c_report">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000831001</identifier>
        </entity>
        <period>
            <startDate>2025-10-02</startDate>
            <endDate>2025-10-02</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="pure">
        <measure>pure</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <ffd:SubmissnTp contextRef="c_report" id="ixv-211">424B2</ffd:SubmissnTp>
    <ffd:FeeExhibitTp contextRef="c_report" id="ixv-212">EX-FILING FEES</ffd:FeeExhibitTp>
    <dei:EntityCentralIndexKey contextRef="c_report" id="ixv-213">0000831001</dei:EntityCentralIndexKey>
    <ffd:RegnFileNb contextRef="c_report" id="ixv-214">333-270327</ffd:RegnFileNb>
    <ffd:FormTp contextRef="c_report" id="ixv-248">S-3</ffd:FormTp>
    <dei:EntityRegistrantName contextRef="c_report" id="ixv-249">Citigroup Inc</dei:EntityRegistrantName>
    <ffd:PrevslyPdFlg contextRef="c_offering_1" id="ixv-250">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp contextRef="c_offering_1" id="ixv-251">Debt</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="c_offering_1" id="ixv-252">Citigroup Global Markets Holdings Inc. Medium-Term Senior Notes, Series N</ffd:OfferingSctyTitl>
    <ffd:Rule457rFlg contextRef="c_offering_1" id="ixv-253">true</ffd:Rule457rFlg>
    <ffd:AmtSctiesRegd
      contextRef="c_offering_1"
      decimals="0"
      id="ixv-254"
      unitRef="shares">521</ffd:AmtSctiesRegd>
    <ffd:MaxOfferingPricPerScty
      contextRef="c_offering_1"
      decimals="INF"
      id="ixv-255"
      unitRef="USD">1000</ffd:MaxOfferingPricPerScty>
    <ffd:MaxAggtOfferingPric
      contextRef="c_offering_1"
      decimals="INF"
      id="ixv-256"
      unitRef="USD">521000</ffd:MaxAggtOfferingPric>
    <ffd:FeeRate
      contextRef="c_offering_1"
      decimals="INF"
      id="ixv-257"
      unitRef="pure">0.0001381</ffd:FeeRate>
    <ffd:FeeAmt
      contextRef="c_offering_1"
      decimals="INF"
      id="ixv-258"
      unitRef="USD">71.95</ffd:FeeAmt>
    <ffd:PrevslyPdFlg contextRef="c_offering_2" id="ixv-259">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp contextRef="c_offering_2" id="ixv-260">Other</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="c_offering_2" id="ixv-261">Citigroup Inc. Guarantee of Medium-Term Senior Notes, Series N</ffd:OfferingSctyTitl>
    <ffd:FeesOthrRuleFlg contextRef="c_offering_2" id="ixv-262">true</ffd:FeesOthrRuleFlg>
    <ffd:AmtSctiesRegd
      contextRef="c_offering_2"
      decimals="0"
      id="ixv-263"
      unitRef="shares">0</ffd:AmtSctiesRegd>
    <ffd:MaxOfferingPricPerScty
      contextRef="c_offering_2"
      decimals="INF"
      id="ixv-264"
      unitRef="USD">0.00</ffd:MaxOfferingPricPerScty>
    <ffd:MaxAggtOfferingPric
      contextRef="c_offering_2"
      decimals="INF"
      id="ixv-265"
      unitRef="USD">0.00</ffd:MaxAggtOfferingPric>
    <ffd:FeeRate
      contextRef="c_offering_2"
      decimals="INF"
      id="ixv-266"
      unitRef="pure">0.0001381</ffd:FeeRate>
    <ffd:FeeAmt
      contextRef="c_offering_2"
      decimals="INF"
      id="ixv-267"
      unitRef="USD">0.00</ffd:FeeAmt>
    <ffd:TtlOfferingAmt
      contextRef="c_report"
      decimals="INF"
      id="ixv-268"
      unitRef="USD">521000</ffd:TtlOfferingAmt>
    <ffd:TtlFeeAmt
      contextRef="c_report"
      decimals="INF"
      id="ixv-269"
      unitRef="USD">71.95</ffd:TtlFeeAmt>
    <ffd:TtlPrevslyPdAmt
      contextRef="c_report"
      decimals="INF"
      id="ixv-270"
      unitRef="USD">0.00</ffd:TtlPrevslyPdAmt>
    <ffd:TtlOffsetAmt
      contextRef="c_report"
      decimals="INF"
      id="ixv-271"
      unitRef="USD">0.00</ffd:TtlOffsetAmt>
    <ffd:NetFeeAmt
      contextRef="c_report"
      decimals="INF"
      id="ixv-272"
      unitRef="USD">71.95</ffd:NetFeeAmt>
    <ffd:OfferingNote contextRef="c_offering_1" id="ixv-273">The filing fee paid with this filing pursuant to Rule 457(r) under the Securities Act of 1933, as amended (the "Securities Act"), was originally deferred in accordance with Rule 456(b) under the
Securities Act.</ffd:OfferingNote>
    <ffd:OfferingNote contextRef="c_offering_2" id="ixv-274">No separate consideration will be received for the guarantee, and pursuant to Rule 457(n) under the Securities Act, no separate registration fee is payable.</ffd:OfferingNote>
    <ffd:NrrtvMaxAggtOfferingPric
      contextRef="c_report"
      decimals="INF"
      id="ixv-275"
      unitRef="USD">521000</ffd:NrrtvMaxAggtOfferingPric>
    <ffd:FnlPrspctsFlg contextRef="c_report" id="ixv-276">true</ffd:FnlPrspctsFlg>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
